| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 3.56e-09 | 6 | 80 | 4 | GO:0008510 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 1.66e-07 | 13 | 80 | 4 | GO:0140410 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 6.09e-07 | 41 | 80 | 5 | GO:0140463 | |
| GeneOntologyMolecularFunction | histone binding | 1.14e-06 | 265 | 80 | 9 | GO:0042393 | |
| GeneOntologyMolecularFunction | histone reader activity | 3.34e-06 | 26 | 80 | 4 | GO:0140566 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 6.05e-06 | 30 | 80 | 4 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 6.92e-06 | 31 | 80 | 4 | GO:0140033 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 7.89e-06 | 32 | 80 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 7.89e-06 | 32 | 80 | 4 | GO:0005452 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | IQCA1L IQCA1 CHD5 MYO18A ACIN1 CHD2 HSP90AB2P HSP90AA5P HSP90AA1 HSP90AA2P | 1.03e-05 | 441 | 80 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.89e-05 | 206 | 80 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 1.96e-05 | 40 | 80 | 4 | GO:0140662 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | IQCA1L IQCA1 ZGRF1 CHD5 MYO18A ACIN1 CHD2 HSP90AB2P HSP90AA5P HSP90AA1 HSP90AA2P | 3.25e-05 | 614 | 80 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | P-TEFb complex binding | 9.46e-05 | 4 | 80 | 2 | GO:0106140 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 1.52e-04 | 126 | 80 | 5 | GO:0051082 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 1.57e-04 | 5 | 80 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | chromatin binding | PARP1 ZNF609 CHAF1A BRD4 CHD5 CHD2 BRD3 NKAPL MECP2 DNAJC2 HP1BP3 | 1.69e-04 | 739 | 80 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | protein folding chaperone | 2.11e-04 | 73 | 80 | 4 | GO:0044183 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | IQCA1L IQCA1 CHD5 MYO18A EIF5B ACIN1 CHD2 HSP90AB2P HSP90AA5P HSP90AA1 HSP90AA2P | 2.56e-04 | 775 | 80 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.14e-04 | 81 | 80 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | IQCA1L IQCA1 CHD5 MYO18A EIF5B ACIN1 CHD2 HSP90AB2P HSP90AA5P HSP90AA1 HSP90AA2P | 5.01e-04 | 839 | 80 | 11 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | IQCA1L IQCA1 CHD5 MYO18A EIF5B ACIN1 CHD2 HSP90AB2P HSP90AA5P HSP90AA1 HSP90AA2P | 5.06e-04 | 840 | 80 | 11 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | IQCA1L IQCA1 CHD5 MYO18A EIF5B ACIN1 CHD2 HSP90AB2P HSP90AA5P HSP90AA1 HSP90AA2P | 5.06e-04 | 840 | 80 | 11 | GO:0016818 |
| GeneOntologyMolecularFunction | disordered domain specific binding | 5.10e-04 | 39 | 80 | 3 | GO:0097718 | |
| GeneOntologyMolecularFunction | microtubule severing ATPase activity | 5.60e-04 | 9 | 80 | 2 | GO:0008568 | |
| GeneOntologyMolecularFunction | GTPase binding | 6.00e-04 | 360 | 80 | 7 | GO:0051020 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 6.22e-04 | 171 | 80 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | translation initiation factor activity | 1.12e-03 | 51 | 80 | 3 | GO:0003743 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.34e-03 | 119 | 80 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 1.61e-03 | 15 | 80 | 2 | GO:0140776 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.70e-03 | 127 | 80 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MED19 MAP1A TCOF1 BAZ2A BRD4 CCAR1 PHF14 AKAP13 BRD3 TRDN MECP2 DNAJC2 | 2.16e-03 | 1160 | 80 | 12 | GO:0030674 |
| GeneOntologyMolecularFunction | antiporter activity | 2.30e-03 | 138 | 80 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 2.89e-03 | 147 | 80 | 4 | GO:0042826 | |
| GeneOntologyMolecularFunction | symporter activity | 3.11e-03 | 150 | 80 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 3.18e-03 | 151 | 80 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.04e-03 | 262 | 80 | 5 | GO:0140097 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 4.83e-03 | 85 | 80 | 3 | GO:0008135 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 4.95e-03 | 171 | 80 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | MED19 MAP1A TCOF1 BAZ2A BRD4 CCAR1 PHF14 AKAP13 BRD3 TRDN MECP2 DNAJC2 | 7.52e-03 | 1356 | 80 | 12 | GO:0060090 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TAF3 MED19 UBN1 BAZ2A BAZ1A CHAF1A BRD4 CHD5 BRD9 PHF14 CHD2 BRD3 TAF7 MECP2 DNAJC2 HP1BP3 | 9.89e-07 | 999 | 79 | 16 | GO:0071824 |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 5.02e-06 | 249 | 79 | 8 | GO:0065004 | |
| GeneOntologyBiologicalProcess | bicarbonate transport | 1.33e-05 | 38 | 79 | 4 | GO:0015701 | |
| GeneOntologyBiologicalProcess | chromatin organization | UBN1 BAZ2A BAZ1A CHAF1A BRD4 CHD5 BRD9 PHF14 CHD2 BRD3 MECP2 DNAJC2 HP1BP3 | 3.32e-05 | 896 | 79 | 13 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | UBN1 BAZ2A BAZ1A CHAF1A BRD4 CHD5 BRD9 CHD2 BRD3 MECP2 HP1BP3 | 1.17e-04 | 741 | 79 | 11 | GO:0006338 |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 1.53e-04 | 515 | 79 | 9 | GO:0022613 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TAF3 MED19 UPF2 PRPF4 BAZ2A BAZ1A RBMX2 FRG1 BRD4 CHD5 HMGXB4 BRD9 DKC1 ACIN1 BOD1L1 TAF7 THOC2 | 1.21e-05 | 1377 | 79 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | proteasome storage granule | 1.41e-05 | 2 | 79 | 2 | GO:0034515 | |
| GeneOntologyCellularComponent | ISWI-type complex | 1.84e-05 | 14 | 79 | 3 | GO:0031010 | |
| GeneOntologyCellularComponent | nuclear body | DOCK1 PARP1 UBN1 PRPF4 BAZ2A RBBP6 FRG1 CHD5 DKC1 ACIN1 AFDN THOC2 HP1BP3 | 3.14e-05 | 903 | 79 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.17e-05 | 96 | 79 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | nuclear speck | 3.56e-05 | 431 | 79 | 9 | GO:0016607 | |
| GeneOntologyCellularComponent | cytoskeletal calyx | 4.22e-05 | 3 | 79 | 2 | GO:0033150 | |
| GeneOntologyCellularComponent | proteasome regulatory particle | 7.60e-05 | 22 | 79 | 3 | GO:0005838 | |
| GeneOntologyCellularComponent | proteasome accessory complex | 1.13e-04 | 25 | 79 | 3 | GO:0022624 | |
| GeneOntologyCellularComponent | proteasome complex | 1.21e-04 | 67 | 79 | 4 | GO:0000502 | |
| GeneOntologyCellularComponent | ATPase complex | 1.29e-04 | 129 | 79 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | perinuclear theca | 1.40e-04 | 5 | 79 | 2 | GO:0033011 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber | 2.93e-04 | 7 | 79 | 2 | GO:0097457 | |
| GeneOntologyCellularComponent | chromatin | PARP1 BAZ2A BAZ1A CHAF1A BRD4 CHD5 HMGXB4 BRD9 ANKRD11 PHF14 CHD2 BRD3 TAF7 MECP2 HP1BP3 | 3.81e-04 | 1480 | 79 | 15 | GO:0000785 |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 4.99e-04 | 9 | 79 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | heterochromatin | 5.84e-04 | 101 | 79 | 4 | GO:0000792 | |
| GeneOntologyCellularComponent | endopeptidase complex | 6.06e-04 | 102 | 79 | 4 | GO:1905369 | |
| GeneOntologyCellularComponent | aminoacyl-tRNA synthetase multienzyme complex | 9.08e-04 | 12 | 79 | 2 | GO:0017101 | |
| GeneOntologyCellularComponent | proteasome regulatory particle, base subcomplex | 9.08e-04 | 12 | 79 | 2 | GO:0008540 | |
| GeneOntologyCellularComponent | distal axon | 1.29e-03 | 435 | 79 | 7 | GO:0150034 | |
| GeneOntologyCellularComponent | peptidase complex | 1.63e-03 | 133 | 79 | 4 | GO:1905368 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex | 1.64e-03 | 16 | 79 | 2 | GO:0005852 | |
| GeneOntologyCellularComponent | eukaryotic 48S preinitiation complex | 2.07e-03 | 18 | 79 | 2 | GO:0033290 | |
| GeneOntologyCellularComponent | eukaryotic 43S preinitiation complex | 2.31e-03 | 19 | 79 | 2 | GO:0016282 | |
| GeneOntologyCellularComponent | translation preinitiation complex | 2.56e-03 | 20 | 79 | 2 | GO:0070993 | |
| GeneOntologyCellularComponent | exon-exon junction complex | 2.83e-03 | 21 | 79 | 2 | GO:0035145 | |
| GeneOntologyCellularComponent | Cajal body | 3.97e-03 | 84 | 79 | 3 | GO:0015030 | |
| Domain | Band3_cytoplasmic_dom | 3.31e-08 | 9 | 77 | 4 | IPR013769 | |
| Domain | Band_3_cyto | 3.31e-08 | 9 | 77 | 4 | PF07565 | |
| Domain | - | 3.31e-08 | 9 | 77 | 4 | 3.40.1100.10 | |
| Domain | HCO3_cotransp | 5.50e-08 | 10 | 77 | 4 | PF00955 | |
| Domain | HCO3_transpt_C | 5.50e-08 | 10 | 77 | 4 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 5.50e-08 | 10 | 77 | 4 | IPR016152 | |
| Domain | HCO3_transpt_euk | 5.50e-08 | 10 | 77 | 4 | IPR003020 | |
| Domain | BROMODOMAIN_1 | 4.10e-07 | 37 | 77 | 5 | PS00633 | |
| Domain | Bromodomain | 4.71e-07 | 38 | 77 | 5 | PF00439 | |
| Domain | Na/HCO3_transpt | 6.70e-07 | 5 | 77 | 3 | IPR003024 | |
| Domain | BROMODOMAIN_2 | 6.97e-07 | 41 | 77 | 5 | PS50014 | |
| Domain | BROMO | 7.88e-07 | 42 | 77 | 5 | SM00297 | |
| Domain | Bromodomain | 7.88e-07 | 42 | 77 | 5 | IPR001487 | |
| Domain | - | 7.88e-07 | 42 | 77 | 5 | 1.20.920.10 | |
| Domain | ANION_EXCHANGER_2 | 2.33e-06 | 7 | 77 | 3 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 2.33e-06 | 7 | 77 | 3 | PS00219 | |
| Domain | Bromodomain_CS | 3.73e-06 | 26 | 77 | 4 | IPR018359 | |
| Domain | PHD | 1.44e-05 | 75 | 77 | 5 | PF00628 | |
| Domain | Cylicin_N | 1.68e-05 | 2 | 77 | 2 | IPR029354 | |
| Domain | CYLC | 1.68e-05 | 2 | 77 | 2 | IPR026189 | |
| Domain | EIF3C_N_dom | 1.68e-05 | 2 | 77 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 1.68e-05 | 2 | 77 | 2 | PF05470 | |
| Domain | Cylicin_N | 1.68e-05 | 2 | 77 | 2 | PF15241 | |
| Domain | EIF3C | 1.68e-05 | 2 | 77 | 2 | IPR027516 | |
| Domain | Fam133 | 1.68e-05 | 2 | 77 | 2 | IPR026766 | |
| Domain | Znf_PHD-finger | 1.85e-05 | 79 | 77 | 5 | IPR019787 | |
| Domain | PHD | 3.31e-05 | 89 | 77 | 5 | SM00249 | |
| Domain | Znf_PHD | 3.68e-05 | 91 | 77 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.53e-05 | 95 | 77 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 4.76e-05 | 96 | 77 | 5 | PS01359 | |
| Domain | PC_rep | 5.02e-05 | 3 | 77 | 2 | PF01851 | |
| Domain | MAP1 | 5.02e-05 | 3 | 77 | 2 | IPR026074 | |
| Domain | Proteasome/cyclosome_rpt | 5.02e-05 | 3 | 77 | 2 | IPR002015 | |
| Domain | BET | 1.00e-04 | 4 | 77 | 2 | PF17035 | |
| Domain | NET_dom | 1.00e-04 | 4 | 77 | 2 | IPR027353 | |
| Domain | DDT | 1.00e-04 | 4 | 77 | 2 | PF02791 | |
| Domain | NET | 1.00e-04 | 4 | 77 | 2 | PS51525 | |
| Domain | Zinc_finger_PHD-type_CS | 1.49e-04 | 65 | 77 | 4 | IPR019786 | |
| Domain | DDT | 1.66e-04 | 5 | 77 | 2 | SM00571 | |
| Domain | WSD | 1.66e-04 | 5 | 77 | 2 | PF15613 | |
| Domain | WHIM1 | 1.66e-04 | 5 | 77 | 2 | PF15612 | |
| Domain | DDT_dom | 1.66e-04 | 5 | 77 | 2 | IPR018501 | |
| Domain | WHIM1_dom | 1.66e-04 | 5 | 77 | 2 | IPR028942 | |
| Domain | WHIM2_dom | 1.66e-04 | 5 | 77 | 2 | IPR028941 | |
| Domain | AT_hook | 1.84e-04 | 27 | 77 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.84e-04 | 27 | 77 | 3 | IPR017956 | |
| Domain | DDT | 2.49e-04 | 6 | 77 | 2 | PS50827 | |
| Domain | Znf_FYVE_PHD | 3.53e-04 | 147 | 77 | 5 | IPR011011 | |
| Domain | - | 4.62e-04 | 8 | 77 | 2 | 3.30.890.10 | |
| Domain | - | 5.17e-04 | 449 | 77 | 8 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 5.97e-04 | 459 | 77 | 8 | IPR013083 | |
| Domain | Methyl_CpG_DNA-bd | 9.01e-04 | 11 | 77 | 2 | IPR001739 | |
| Domain | MBD | 9.01e-04 | 11 | 77 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 9.01e-04 | 11 | 77 | 2 | IPR016177 | |
| Domain | MBD | 9.01e-04 | 11 | 77 | 2 | SM00391 | |
| Domain | MBD | 9.01e-04 | 11 | 77 | 2 | PS50982 | |
| Domain | PINT | 1.94e-03 | 16 | 77 | 2 | SM00088 | |
| Domain | AT_hook | 1.94e-03 | 16 | 77 | 2 | PF02178 | |
| Domain | PCI_dom | 2.19e-03 | 17 | 77 | 2 | IPR000717 | |
| Domain | PCI | 2.19e-03 | 17 | 77 | 2 | PF01399 | |
| Domain | ARM-type_fold | 2.75e-03 | 339 | 77 | 6 | IPR016024 | |
| Domain | - | 3.04e-03 | 20 | 77 | 2 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 3.04e-03 | 20 | 77 | 2 | IPR001279 | |
| Domain | - | 3.35e-03 | 21 | 77 | 2 | 1.10.720.30 | |
| Domain | SAP | 3.67e-03 | 22 | 77 | 2 | PF02037 | |
| Domain | SAP | 4.01e-03 | 23 | 77 | 2 | SM00513 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 4.28e-08 | 10 | 55 | 4 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 4.28e-08 | 10 | 55 | 4 | MM15073 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | EPRS1 FAM32A UPF2 PRPF4 RBMX2 CCAR1 DKC1 ACIN1 PSMD1 PSMD2 PSMD7 RPS25 THOC2 PSMA8 | 4.79e-07 | 724 | 55 | 14 | M16843 |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 9.22e-06 | 73 | 55 | 5 | MM15491 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.11e-05 | 36 | 55 | 4 | M47758 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.11e-05 | 36 | 55 | 4 | M47713 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.11e-05 | 36 | 55 | 4 | M47714 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.11e-05 | 36 | 55 | 4 | M47702 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.36e-05 | 79 | 55 | 5 | M27743 | |
| Pathway | KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.54e-05 | 39 | 55 | 4 | M47701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.71e-05 | 40 | 55 | 4 | M47749 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.71e-05 | 40 | 55 | 4 | M47748 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION | 1.89e-05 | 41 | 55 | 4 | M47747 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | FAM32A UPF2 PRPF4 RBMX2 ACIN1 PSMD1 PSMD2 PSMD7 RPS25 THOC2 PSMA8 | 1.98e-05 | 612 | 55 | 11 | MM15547 |
| Pathway | KEGG_PROTEASOME | 3.00e-05 | 46 | 55 | 4 | M10680 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | 3.55e-05 | 48 | 55 | 4 | MM14528 | |
| Pathway | REACTOME_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A | 4.18e-05 | 50 | 55 | 4 | MM15385 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | 4.18e-05 | 50 | 55 | 4 | M510 | |
| Pathway | REACTOME_DEGRADATION_OF_AXIN | 5.27e-05 | 53 | 55 | 4 | MM15152 | |
| Pathway | REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS | 5.34e-05 | 172 | 55 | 6 | M27876 | |
| Pathway | REACTOME_STABILIZATION_OF_P53 | 5.67e-05 | 54 | 55 | 4 | MM15384 | |
| Pathway | REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA | 6.10e-05 | 55 | 55 | 4 | MM15137 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 6.10e-05 | 55 | 55 | 4 | MM15153 | |
| Pathway | REACTOME_DEGRADATION_OF_AXIN | 6.10e-05 | 55 | 55 | 4 | M27398 | |
| Pathway | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | 6.10e-05 | 55 | 55 | 4 | M17095 | |
| Pathway | REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA | 6.10e-05 | 55 | 55 | 4 | M998 | |
| Pathway | REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING | 6.55e-05 | 56 | 55 | 4 | MM15203 | |
| Pathway | REACTOME_STABILIZATION_OF_P53 | 7.03e-05 | 57 | 55 | 4 | M27670 | |
| Pathway | REACTOME_METABOLISM_OF_POLYAMINES | 7.03e-05 | 57 | 55 | 4 | MM14955 | |
| Pathway | REACTOME_DEGRADATION_OF_DVL | 7.03e-05 | 57 | 55 | 4 | M27399 | |
| Pathway | REACTOME_GLI3_IS_PROCESSED_TO_GLI3R_BY_THE_PROTEASOME | 7.03e-05 | 57 | 55 | 4 | MM15205 | |
| Pathway | REACTOME_METABOLISM_OF_POLYAMINES | 8.05e-05 | 59 | 55 | 4 | M747 | |
| Pathway | REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME | 8.60e-05 | 60 | 55 | 4 | M27470 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 8.60e-05 | 60 | 55 | 4 | MM15150 | |
| Pathway | REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS | 9.18e-05 | 61 | 55 | 4 | M27563 | |
| Pathway | REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING | 9.78e-05 | 62 | 55 | 4 | M27465 | |
| Pathway | REACTOME_HEDGEHOG_LIGAND_BIOGENESIS | 9.78e-05 | 62 | 55 | 4 | MM15181 | |
| Pathway | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | 9.78e-05 | 62 | 55 | 4 | MM14514 | |
| Pathway | REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS | 1.11e-04 | 64 | 55 | 4 | MM15386 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 1.11e-04 | 64 | 55 | 4 | M27396 | |
| Pathway | REACTOME_HEDGEHOG_LIGAND_BIOGENESIS | 1.18e-04 | 65 | 55 | 4 | M27439 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | 1.18e-04 | 65 | 55 | 4 | MM15530 | |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 1.25e-04 | 66 | 55 | 4 | MM15261 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | PARP1 TAF3 MED19 MAP1B BRD4 PSMD1 PSMD2 PSMD7 RPS25 TAF7 PSMA8 HSP90AA1 | 1.28e-04 | 888 | 55 | 12 | M48034 |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 1.40e-04 | 68 | 55 | 4 | M27539 | |
| Pathway | REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS | 1.40e-04 | 68 | 55 | 4 | M27672 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 1.49e-04 | 69 | 55 | 4 | MM15540 | |
| Pathway | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | 1.49e-04 | 69 | 55 | 4 | MM15366 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA | 1.49e-04 | 69 | 55 | 4 | MM14522 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY | 1.49e-04 | 69 | 55 | 4 | M27815 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 1.65e-04 | 211 | 55 | 6 | M27436 | |
| Pathway | REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6 | 1.66e-04 | 71 | 55 | 4 | MM15370 | |
| Pathway | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | 1.66e-04 | 71 | 55 | 4 | M4138 | |
| Pathway | REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY | 1.75e-04 | 72 | 55 | 4 | M27802 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 1.85e-04 | 73 | 55 | 4 | MM15285 | |
| Pathway | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | 1.95e-04 | 74 | 55 | 4 | M1030 | |
| Pathway | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | 1.95e-04 | 74 | 55 | 4 | MM14678 | |
| Pathway | REACTOME_SIGNALING_BY_ROBO_RECEPTORS | 1.97e-04 | 218 | 55 | 6 | M2780 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA | 2.05e-04 | 75 | 55 | 4 | M641 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | DOCK1 PARP1 TAF3 MED19 MAP1B BRD4 PSMD1 PSMD2 PSMD7 RPS25 TAF7 PSMA8 HSP90AA1 | 2.05e-04 | 1081 | 55 | 13 | M27548 |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 2.16e-04 | 76 | 55 | 4 | MM14526 | |
| Pathway | REACTOME_ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | 2.27e-04 | 77 | 55 | 4 | MM14692 | |
| Pathway | REACTOME_KEAP1_NFE2L2_PATHWAY | 2.27e-04 | 77 | 55 | 4 | MM15698 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | 2.27e-04 | 77 | 55 | 4 | MM14513 | |
| Pathway | REACTOME_ABC_TRANSPORTER_DISORDERS | 2.39e-04 | 78 | 55 | 4 | M27473 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 2.51e-04 | 79 | 55 | 4 | MM14754 | |
| Pathway | REACTOME_HIV_INFECTION | 2.69e-04 | 231 | 55 | 6 | M12469 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | 2.76e-04 | 81 | 55 | 4 | M595 | |
| Pathway | REACTOME_HEDGEHOG_ON_STATE | 2.76e-04 | 81 | 55 | 4 | MM15225 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 3.32e-04 | 85 | 55 | 4 | MM15041 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 3.32e-04 | 85 | 55 | 4 | M27079 | |
| Pathway | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | 3.47e-04 | 86 | 55 | 4 | MM15140 | |
| Pathway | REACTOME_HEDGEHOG_ON_STATE | 3.47e-04 | 86 | 55 | 4 | M27497 | |
| Pathway | REACTOME_UCH_PROTEINASES | 3.63e-04 | 87 | 55 | 4 | MM15287 | |
| Pathway | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | 3.63e-04 | 87 | 55 | 4 | M944 | |
| Pathway | REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS | 3.63e-04 | 87 | 55 | 4 | MM14677 | |
| Pathway | REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS | 3.79e-04 | 88 | 55 | 4 | M29582 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 4.13e-04 | 90 | 55 | 4 | MM15371 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 4.49e-04 | 92 | 55 | 4 | M27666 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 4.49e-04 | 92 | 55 | 4 | M27322 | |
| Pathway | REACTOME_DOWNSTREAM_TCR_SIGNALING | 4.68e-04 | 93 | 55 | 4 | MM14806 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 4.68e-04 | 93 | 55 | 4 | M27572 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 4.68e-04 | 93 | 55 | 4 | MM15204 | |
| Pathway | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | 5.21e-04 | 366 | 55 | 7 | M727 | |
| Pathway | REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY | 5.49e-04 | 97 | 55 | 4 | MM15268 | |
| Pathway | REACTOME_PTEN_REGULATION | 5.71e-04 | 98 | 55 | 4 | MM15348 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 5.93e-04 | 99 | 55 | 4 | MM14986 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 6.16e-04 | 100 | 55 | 4 | M27467 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 6.17e-04 | 177 | 55 | 5 | M27476 | |
| Pathway | REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY | 6.40e-04 | 101 | 55 | 4 | M27552 | |
| Pathway | REACTOME_APOPTOSIS | 6.50e-04 | 179 | 55 | 5 | M15303 | |
| Pathway | REACTOME_UCH_PROTEINASES | 6.64e-04 | 102 | 55 | 4 | M27576 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 6.89e-04 | 103 | 55 | 4 | M758 | |
| Pathway | REACTOME_INTERLEUKIN_1_SIGNALING | 7.14e-04 | 104 | 55 | 4 | MM17224 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 7.36e-04 | 184 | 55 | 5 | MM15145 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 7.40e-04 | 105 | 55 | 4 | MM15206 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 7.67e-04 | 106 | 55 | 4 | M518 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 7.88e-04 | 283 | 55 | 6 | M13087 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 7.95e-04 | 107 | 55 | 4 | MM14915 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 8.23e-04 | 108 | 55 | 4 | M823 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PARP1 TAF3 SFSWAP FAM32A MAP1A MAP1B UPF2 TCOF1 MYCBP2 USP42 PRPF4 RBBP6 RBMX2 FRG1 BRD4 HMGXB4 MYO18A EIF5B CCAR1 DKC1 ACIN1 CHD2 BRD3 RPS25 EIF3C THOC2 NKAPL MECP2 AP3D1 HSP90AA1 HP1BP3 | 6.56e-26 | 1082 | 81 | 31 | 38697112 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EPRS1 PARP1 ZNF609 TAF3 MED19 UBN1 SFSWAP MAP1B PRPF4 BAZ2A BAZ1A RBBP6 CHAF1A BRD4 HMGXB4 BRD9 ANKRD11 EIF5B CCAR1 DKC1 ACIN1 AFDN PHF14 BOD1L1 RPS25 THOC2 MECP2 HSP90AA1 HP1BP3 | 7.05e-25 | 954 | 81 | 29 | 36373674 |
| Pubmed | CYLC1 SMIM24 CYLC2 FAM133B EPRS1 PARP1 MAP1B FAM133A BAZ1A RBMX2 CHAF1A CHD5 SEC62 UBR4 MYO18A EIF5B CCAR1 DKC1 ACIN1 PSMD1 PSMD2 PHF14 BOD1L1 PSMD7 CHD2 BRD3 RPS25 TRDN MECP2 PSMA8 AP3D1 HSP90AA1 HP1BP3 | 1.33e-24 | 1442 | 81 | 33 | 35575683 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RABL6 FAM133B EPRS1 PARP1 TAF3 MED19 UPF2 TCOF1 USP42 AIMP1 PRPF4 BAZ2A RBBP6 RBMX2 FRG1 CHAF1A UBR4 BRD9 EIF5B CCAR1 DKC1 ACIN1 PSMD2 PSMD7 CHD2 RPS25 THOC2 PSMA8 AP3D1 HSP90AA1 HP1BP3 EIF3CL | 1.37e-24 | 1318 | 81 | 32 | 30463901 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EPRS1 TAF3 UBN1 SFSWAP TCOF1 MYCBP2 USP42 BAZ2A RBBP6 RBMX2 CHAF1A BRD4 MYO18A EIF5B CCAR1 DKC1 ACIN1 PSMD1 AFDN PHF14 BRD3 EIF3C PARD3 THOC2 MECP2 EIF3CL | 2.55e-23 | 774 | 81 | 26 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPRS1 PARP1 ZNF609 UBN1 SFSWAP TCOF1 USP42 PRPF4 BAZ2A BAZ1A RBBP6 RBMX2 FRG1 CHAF1A BRD4 HMGXB4 ANKRD11 CCAR1 DKC1 ACIN1 PHF14 CHD2 BRD3 RPS25 TAF7 THOC2 MECP2 HP1BP3 | 4.77e-20 | 1294 | 81 | 28 | 30804502 |
| Pubmed | PARP1 TAF3 MED19 UBN1 PRPF4 BAZ1A RBBP6 CHAF1A BRD4 UBR4 BRD9 EIF5B CCAR1 DKC1 ACIN1 PHF14 BOD1L1 CHD2 BRD3 TAF7 THOC2 HSP90AA1 HP1BP3 | 7.32e-17 | 1014 | 81 | 23 | 32416067 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FAM133B EPRS1 PARP1 TCOF1 RBBP6 RBMX2 FRG1 CHD5 BRD9 MYO18A EIF5B DKC1 PSMD2 RPS25 EIF3C THOC2 HSP90AA5P AP3D1 HSP90AA1 HP1BP3 EIF3CL HSP90AA2P | 2.49e-16 | 949 | 81 | 22 | 36574265 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PARP1 TAF3 UBN1 BAZ2A BAZ1A RBMX2 FRG1 CHAF1A BRD4 CHD5 HMGXB4 BRD9 PHF14 BOD1L1 CHD2 BRD3 MECP2 HP1BP3 | 2.98e-15 | 608 | 81 | 18 | 36089195 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 PARP1 UBN1 MAP1B UPF2 MYCBP2 BAZ2A BAZ1A UBR4 EIF5B CCAR1 DKC1 ACIN1 PSMD1 PSMD2 AFDN AKAP13 PSMD7 CHD2 RPS25 HSP90AB2P PARD3 AP3D1 HSP90AA1 | 3.25e-15 | 1353 | 81 | 24 | 29467282 |
| Pubmed | EPRS1 PARP1 TAF3 MED19 SFSWAP FAM32A UPF2 TCOF1 FAM133A AIMP1 BAZ1A RBMX2 FRG1 SEC62 CCAR1 DKC1 ACIN1 CHD2 PARD3 THOC2 MECP2 PSMA8 AP3D1 HP1BP3 | 4.34e-15 | 1371 | 81 | 24 | 36244648 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | TAF3 MED19 BAZ1A CHAF1A BRD4 HMGXB4 BRD9 EIF5B DKC1 ACIN1 CHD2 BRD3 TAF7 THOC2 MECP2 HP1BP3 EIF3CL | 5.73e-15 | 533 | 81 | 17 | 30554943 |
| Pubmed | EPRS1 PARP1 MAP1B TCOF1 MYCBP2 AIMP1 BAZ2A EIF5B CCAR1 ACIN1 PSMD1 PSMD2 BOD1L1 RPS25 EIF3C THOC2 AP3D1 HSP90AA1 HP1BP3 | 2.94e-14 | 809 | 81 | 19 | 32129710 | |
| Pubmed | FAM133B MED19 SLC4A7 SFSWAP BAZ2A BAZ1A RBBP6 RBMX2 FRG1 CHAF1A HMGXB4 BRD9 ANKRD11 EIF5B CCAR1 AFDN PHF14 CHD2 BRD3 EIF3C HSP90AB2P PARD3 MECP2 DNAJC2 | 2.97e-14 | 1497 | 81 | 24 | 31527615 | |
| Pubmed | TAF3 USP42 BAZ1A RBBP6 FRG1 CHAF1A BRD4 CCAR1 ACIN1 PHF14 BOD1L1 CHD2 BRD3 TAF7 MECP2 | 2.56e-13 | 469 | 81 | 15 | 27634302 | |
| Pubmed | EPRS1 PARP1 TCOF1 AIMP1 PRPF4 FRG1 CHD5 CCAR1 PSMD1 PSMD2 PSMD7 CHD2 RPS25 EIF3C HSP90AB2P HSP90AA5P PSMA8 HSP90AA1 HP1BP3 HSP90AA2P | 1.51e-12 | 1153 | 81 | 20 | 29845934 | |
| Pubmed | EPRS1 PARP1 AIMP1 PRPF4 UBR4 EIF5B CCAR1 DKC1 PSMD1 PSMD2 PSMD7 RPS25 EIF3C THOC2 AP3D1 HSP90AA1 | 1.52e-12 | 638 | 81 | 16 | 33239621 | |
| Pubmed | EPRS1 PARP1 MAP1A MAP1B TCOF1 AIMP1 PRPF4 WDR87 EIF5B DKC1 PSMD1 PSMD2 PSMD7 RPS25 EIF3C HSP90AB2P HSP90AA5P PSMA8 HSP90AA1 HP1BP3 HSP90AA2P | 2.40e-12 | 1335 | 81 | 21 | 29229926 | |
| Pubmed | 2.68e-12 | 103 | 81 | 9 | 32744500 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 PARP1 MAP1A MAP1B TCOF1 BAZ2A BAZ1A RBBP6 EIF5B DKC1 ACIN1 BOD1L1 PSMD7 EIF3C THOC2 AP3D1 HSP90AA1 HP1BP3 | 4.19e-12 | 934 | 81 | 18 | 33916271 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SMAP1 EPRS1 PARP1 SLC4A7 TCOF1 AIMP1 PRPF4 FRG1 UBR4 EIF5B DKC1 PSMD1 PSMD2 AKAP13 RPS25 EIF3C HSP90AB2P AP3D1 HSP90AA1 DNAJC2 HP1BP3 | 7.17e-12 | 1415 | 81 | 21 | 28515276 |
| Pubmed | DOCK1 RABL6 EPRS1 PARP1 MAP1B TCOF1 EIF5B PSMD1 PSMD2 AFDN BOD1L1 RPS25 TAF7 PARD3 AP3D1 HSP90AA1 | 7.24e-12 | 708 | 81 | 16 | 39231216 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 PARP1 TCOF1 AIMP1 PRPF4 BAZ1A CHAF1A UBR4 EIF5B CCAR1 DKC1 ACIN1 PSMD1 PSMD2 AFDN BOD1L1 PSMD7 RPS25 EIF3C THOC2 EIF3CL | 8.18e-12 | 1425 | 81 | 21 | 30948266 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | EPRS1 PARP1 SFSWAP TCOF1 PRPF4 BAZ1A CHD5 CCAR1 DKC1 ACIN1 PHF14 RPS25 EIF3C HSP90AA1 HP1BP3 | 9.63e-12 | 605 | 81 | 15 | 28977666 |
| Pubmed | DOCK1 EPRS1 TCOF1 RBBP6 CHAF1A EIF5B DKC1 ACIN1 PSMD1 AFDN AKAP13 EIF3C THOC2 EIF3CL | 1.10e-11 | 503 | 81 | 14 | 16964243 | |
| Pubmed | SMAP1 EPRS1 SLC4A7 SLC4A8 MAP1A MAP1B MYCBP2 AIMP1 SEC62 UBR4 MYO18A PSMD1 PSMD2 AFDN PSMD7 EIF3C SLC4A4 HSP90AA1 EIF3CL | 1.18e-11 | 1139 | 81 | 19 | 36417873 | |
| Pubmed | FAM133B PARP1 SFSWAP PRPF4 RBBP6 RBMX2 CCAR1 ACIN1 BOD1L1 BRD3 HP1BP3 | 1.73e-11 | 251 | 81 | 11 | 31076518 | |
| Pubmed | PARP1 MAP1B AIMP1 MYO18A EIF5B PSMD1 PSMD2 PHF14 PSMD7 RPS25 EIF3C HP1BP3 | 1.98e-11 | 334 | 81 | 12 | 30425250 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | FAM133B MAP1B UPF2 MYCBP2 AIMP1 PRPF4 BAZ1A RBBP6 FRG1 MYO18A DKC1 ACIN1 RPS25 THOC2 AP3D1 HP1BP3 | 2.04e-11 | 759 | 81 | 16 | 35915203 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | UPF2 TCOF1 BAZ2A RBBP6 FRG1 UBR4 EIF5B ACIN1 EIF3C TAF7 AP3D1 HP1BP3 | 2.51e-11 | 341 | 81 | 12 | 32971831 |
| Pubmed | EPRS1 TAF3 MAP1B TCOF1 MYCBP2 BAZ2A RBBP6 BRD4 ACIN1 AFDN BOD1L1 TAF7 PARD3 THOC2 | 3.50e-11 | 549 | 81 | 14 | 38280479 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ZNF609 TCOF1 RBBP6 BRD4 UBR4 CCAR1 ACIN1 PSMD2 AFDN PSMD7 BRD3 EIF3C DNAJC2 HP1BP3 EIF3CL | 3.63e-11 | 665 | 81 | 15 | 30457570 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 PARP1 UPF2 AIMP1 PRPF4 RBBP6 FRG1 CHD5 MYO18A EIF5B ACIN1 PSMD2 RPS25 THOC2 MECP2 HSP90AA1 DNAJC2 HP1BP3 EIF3CL | 6.32e-11 | 1257 | 81 | 19 | 36526897 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RABL6 FAM133B MED19 SFSWAP FAM32A FAM133A RBBP6 RBMX2 BRD9 CCAR1 AKAP13 EIF3C HSP90AA1 DNAJC2 EIF3CL | 7.56e-11 | 701 | 81 | 15 | 30196744 |
| Pubmed | PARP1 SFSWAP MAP1B HMGXB4 BRD9 AFDN RPS25 HSP90AB2P NKAPL HSP90AA2P | 8.47e-11 | 215 | 81 | 10 | 35973513 | |
| Pubmed | EPRS1 SFSWAP TCOF1 AIMP1 PRPF4 BAZ1A RBBP6 CCAR1 DKC1 ACIN1 BRD3 RPS25 EIF3C THOC2 HSP90AA1 HP1BP3 | 1.02e-10 | 847 | 81 | 16 | 35850772 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | PARP1 SFSWAP TCOF1 USP42 FRG1 CHAF1A CCAR1 DKC1 ACIN1 PSMD2 PHF14 BOD1L1 RPS25 EIF3C HSP90AB2P THOC2 HSP90AA1 | 1.06e-10 | 989 | 81 | 17 | 36424410 |
| Pubmed | EPRS1 PARP1 SFSWAP TCOF1 AIMP1 PRPF4 RBBP6 RBMX2 DKC1 ACIN1 RPS25 EIF3C THOC2 HSP90AA1 HP1BP3 | 1.35e-10 | 731 | 81 | 15 | 29298432 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 PARP1 MAP1B TCOF1 MYCBP2 PRPF4 BAZ1A EIF5B DKC1 ACIN1 PSMD1 PSMD2 AFDN RPS25 EIF3C THOC2 HP1BP3 | 1.80e-10 | 1024 | 81 | 17 | 24711643 |
| Pubmed | MAP1B TCOF1 MYCBP2 BAZ2A UBR4 EIF5B CCAR1 ACIN1 PSMD1 PSMD2 AFDN CHD2 THOC2 HP1BP3 | 3.38e-10 | 653 | 81 | 14 | 22586326 | |
| Pubmed | EPRS1 PARP1 UPF2 CHAF1A DKC1 PSMD1 PSMD2 RPS25 EIF3C HSP90AB2P HSP90AA5P HSP90AA1 HSP90AA2P | 3.62e-10 | 538 | 81 | 13 | 28524877 | |
| Pubmed | RABL6 EPRS1 SFSWAP AIMP1 PRPF4 MYO18A DKC1 ACIN1 PSMD1 PSMD2 CCDC80 PSMD7 EIF3C AP3D1 HP1BP3 | 3.67e-10 | 786 | 81 | 15 | 29128334 | |
| Pubmed | ZNF609 TAF3 SFSWAP MAP1A TCOF1 PRPF4 BAZ2A RBBP6 CHAF1A BRD4 CHD5 HMGXB4 BRD9 BRD3 TAF7 PARD3 MECP2 | 6.68e-10 | 1116 | 81 | 17 | 31753913 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 PARP1 UPF2 AIMP1 ZGRF1 BOD1L1 PSMD7 RPS25 EIF3C HSP90AB2P THOC2 HSP90AA5P AP3D1 HSP90AA1 HSP90AA2P | 1.02e-09 | 847 | 81 | 15 | 35235311 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 PARP1 MAP1B TCOF1 MYCBP2 AIMP1 UBR4 MYO18A EIF5B PSMD1 PSMD2 AFDN PSMD7 RPS25 AP3D1 HSP90AA1 EIF3CL | 1.04e-09 | 1149 | 81 | 17 | 35446349 |
| Pubmed | EPRS1 PARP1 TCOF1 AIMP1 EIF5B PSMD1 PSMD2 PSMD7 RPS25 HSP90AB2P HSP90AA1 HP1BP3 | 1.72e-09 | 494 | 81 | 12 | 26831064 | |
| Pubmed | EPRS1 MAP1B TCOF1 AIMP1 CCAR1 PSMD1 PSMD2 PSMD7 EIF3C HSP90AA1 | 3.98e-09 | 320 | 81 | 10 | 28685749 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPRS1 PARP1 AIMP1 BAZ1A CHAF1A UBR4 HMGXB4 ACIN1 BOD1L1 HSP90AA1 | 5.66e-09 | 332 | 81 | 10 | 32786267 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 9.10e-09 | 349 | 81 | 10 | 25665578 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZNF609 MAP1A MAP1B UPF2 MYCBP2 BRD9 MYO18A EIF5B CCAR1 DKC1 AKAP13 RPS25 TAF7 | 1.27e-08 | 724 | 81 | 13 | 36232890 |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 1.39e-08 | 269 | 81 | 9 | 29511261 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | PARP1 ZNF609 SLC4A7 TCOF1 USP42 RBBP6 BRD4 SEC62 PSMD1 PSMD2 AFDN CHD2 THOC2 MECP2 AP3D1 HP1BP3 | 1.54e-08 | 1203 | 81 | 16 | 29180619 |
| Pubmed | 1.63e-08 | 191 | 81 | 8 | 20195357 | ||
| Pubmed | 1.83e-08 | 72 | 81 | 6 | 31248990 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.39e-08 | 130 | 81 | 7 | 35545047 | |
| Pubmed | 2.52e-08 | 202 | 81 | 8 | 24639526 | ||
| Pubmed | ZNF609 TAF3 UBN1 AIMP1 RBBP6 CHD5 UBR4 HMGXB4 BRD9 MYO18A CCAR1 PSMD1 PSMD2 PSMD7 RPS25 EIF3C HP1BP3 | 2.62e-08 | 1429 | 81 | 17 | 35140242 | |
| Pubmed | SMAP1 EPRS1 PARP1 MAP1A MAP1B UPF2 MYO18A PSMD2 AFDN RPS25 EIF3C SLC4A4 MECP2 AP3D1 HSP90AA1 HP1BP3 EIF3CL | 2.68e-08 | 1431 | 81 | 17 | 37142655 | |
| Pubmed | 2.68e-08 | 14 | 81 | 4 | 21151955 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | EPRS1 PARP1 MYCBP2 AIMP1 UBR4 DKC1 PSMD1 PSMD2 PSMD7 RPS25 EIF3C HSP90AB2P THOC2 NKAPL HSP90AA1 EIF3CL | 2.84e-08 | 1257 | 81 | 16 | 37317656 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.86e-08 | 394 | 81 | 10 | 27248496 | |
| Pubmed | EPRS1 PARP1 TCOF1 AIMP1 DKC1 ACIN1 RPS25 EIF3C SLC4A5 AP3D1 HSP90AA1 DNAJC2 | 3.08e-08 | 641 | 81 | 12 | 36057605 | |
| Pubmed | 3.55e-08 | 300 | 81 | 9 | 28561026 | ||
| Pubmed | PARP1 TCOF1 RBBP6 CHAF1A CCAR1 DKC1 PSMD1 PSMD2 RPS25 THOC2 HSP90AA1 HP1BP3 | 3.71e-08 | 652 | 81 | 12 | 31180492 | |
| Pubmed | Molecular expression of SLC4-derived Na+-dependent anion transporters in selected human tissues. | 4.86e-08 | 4 | 81 | 3 | 17715183 | |
| Pubmed | The HSP90 family of genes in the human genome: insights into their divergence and evolution. | 4.86e-08 | 16 | 81 | 4 | 16269234 | |
| Pubmed | EPRS1 PARP1 UPF2 TCOF1 PRPF4 RBMX2 FRG1 EIF5B PSMD1 PSMD2 PSMD7 RPS25 HSP90AA1 EIF3CL | 5.12e-08 | 971 | 81 | 14 | 33306668 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | EPRS1 PARP1 ZNF609 MAP1B AIMP1 PSMD1 PSMD2 RPS25 EIF3C HSP90AA1 HSP90AA2P | 7.23e-08 | 558 | 81 | 11 | 27591049 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 8.11e-08 | 235 | 81 | 8 | 30258100 | |
| Pubmed | EPRS1 PARP1 TCOF1 BRD4 EIF5B DKC1 EIF3C MECP2 HSP90AA1 HP1BP3 | 8.17e-08 | 441 | 81 | 10 | 31239290 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SMAP1 PARP1 MAP1B TCOF1 AIMP1 UBR4 MYO18A EIF5B CCAR1 ACIN1 PSMD2 AFDN RPS25 EIF3C HSP90AA1 HP1BP3 | 8.97e-08 | 1367 | 81 | 16 | 32687490 |
| Pubmed | SFSWAP UPF2 PRPF4 RBBP6 FRG1 EIF5B CCAR1 DKC1 ACIN1 RPS25 THOC2 HP1BP3 | 9.77e-08 | 713 | 81 | 12 | 29802200 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | EPRS1 PARP1 MAP1B PRPF4 PSMD1 RPS25 EIF3C HSP90AB2P PSMA8 AP3D1 HSP90AA1 HP1BP3 | 9.92e-08 | 714 | 81 | 12 | 28302793 |
| Pubmed | 1.23e-07 | 347 | 81 | 9 | 17114649 | ||
| Pubmed | 1.30e-07 | 250 | 81 | 8 | 33536335 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.60e-07 | 358 | 81 | 9 | 32460013 | |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | FAM133B PARP1 SLC4A7 TCOF1 FRG1 DKC1 PSMD1 PSMD2 PSMD7 RPS25 HSP90AA1 | 1.60e-07 | 604 | 81 | 11 | 37616343 |
| Pubmed | 1.67e-07 | 104 | 81 | 6 | 31365120 | ||
| Pubmed | EPRS1 PARP1 ZNF609 TCOF1 PRPF4 RBBP6 WDR87 EIF5B ACIN1 PSMD1 PSMD2 RPS25 PARD3 THOC2 HSP90AA1 | 1.69e-07 | 1247 | 81 | 15 | 27684187 | |
| Pubmed | 1.71e-07 | 259 | 81 | 8 | 31162944 | ||
| Pubmed | PARP1 UBN1 MAP1B AIMP1 SEC62 UBR4 EIF5B DKC1 PSMD1 PSMD2 PSMD7 EIF3C HSP90AB2P THOC2 AP3D1 HSP90AA1 | 1.81e-07 | 1440 | 81 | 16 | 30833792 | |
| Pubmed | EPRS1 PARP1 FAM32A TCOF1 AIMP1 MYO18A PSMD2 RPS25 AP3D1 HSP90AA1 | 2.08e-07 | 488 | 81 | 10 | 31324722 | |
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 2.10e-07 | 56 | 81 | 5 | 26919559 | |
| Pubmed | 2.30e-07 | 57 | 81 | 5 | 21555454 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.41e-07 | 271 | 81 | 8 | 32433965 | |
| Pubmed | EPRS1 PARP1 ZNF609 FAM32A MYCBP2 PRPF4 FRG1 BRD4 BRD9 EIF5B CCAR1 PSMD7 THOC2 MECP2 | 2.42e-07 | 1103 | 81 | 14 | 34189442 | |
| Pubmed | An engineered cell line with a hRpn1-attached handle to isolate proteasomes. | 2.42e-07 | 6 | 81 | 3 | 37354974 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SMAP1 EPRS1 SLC4A7 SFSWAP TCOF1 MYCBP2 CHAF1A UBR4 ACIN1 PSMD1 PSMD2 AFDN AKAP13 PSMD7 PARD3 | 2.46e-07 | 1284 | 81 | 15 | 17353931 |
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 2.74e-07 | 59 | 81 | 5 | 16083285 | |
| Pubmed | PARP1 SLC4A7 TCOF1 MYCBP2 BAZ2A UBR4 MYO18A ANKRD11 EIF5B AKAP13 PSMD7 RPS25 PARD3 AP3D1 DNAJC2 HP1BP3 | 2.79e-07 | 1487 | 81 | 16 | 33957083 | |
| Pubmed | PARP1 TCOF1 MYCBP2 BAZ1A RBBP6 SEC62 UBR4 EIF5B CCAR1 PSMD2 AKAP13 BOD1L1 RPS25 AP3D1 HSP90AA1 | 2.80e-07 | 1297 | 81 | 15 | 33545068 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 ZNF609 MAP1B MYCBP2 AIMP1 ANKRD11 CCAR1 PSMD1 PHF14 AKAP13 BOD1L1 CHD2 PARD3 SH3RF3 SLC4A5 HP1BP3 | 2.84e-07 | 1489 | 81 | 16 | 28611215 |
| Pubmed | MED19 UBN1 MAP1B MYCBP2 FRG1 CHAF1A CCAR1 PSMD7 BRD3 THOC2 MECP2 | 3.07e-07 | 645 | 81 | 11 | 25281560 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 3.17e-07 | 281 | 81 | 8 | 30455355 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.35e-07 | 283 | 81 | 8 | 30585729 | |
| Pubmed | RABL6 PARP1 AIMP1 RBBP6 FRG1 SEC62 DKC1 PSMD1 PSMD2 PSMD7 EIF3C | 3.47e-07 | 653 | 81 | 11 | 33742100 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | FAM133B PARP1 TCOF1 RBBP6 MYO18A EIF5B CCAR1 ACIN1 CHD2 RPS25 EIF3C HSP90AA1 | 3.67e-07 | 807 | 81 | 12 | 22681889 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 PARP1 MYCBP2 UBR4 EIF5B PSMD1 PSMD2 AKAP13 RPS25 AP3D1 HSP90AA1 HP1BP3 | 3.67e-07 | 807 | 81 | 12 | 30575818 |
| Pubmed | 3.96e-07 | 399 | 81 | 9 | 35987950 | ||
| Pubmed | 4.48e-07 | 65 | 81 | 5 | 28276505 | ||
| Interaction | MECP2 interactions | PARP1 TAF3 SFSWAP FAM32A MAP1A MAP1B UPF2 TCOF1 MYCBP2 USP42 PRPF4 BAZ1A RBBP6 RBMX2 FRG1 BRD4 HMGXB4 MYO18A EIF5B CCAR1 DKC1 ACIN1 PHF14 CHD2 BRD3 RPS25 EIF3C THOC2 NKAPL MECP2 AP3D1 HSP90AA1 HP1BP3 | 6.84e-19 | 1287 | 81 | 33 | int:MECP2 |
| Interaction | NR2C2 interactions | RABL6 FAM133B EPRS1 PARP1 TAF3 MED19 UBN1 UPF2 TCOF1 USP42 AIMP1 PRPF4 BAZ2A RBBP6 RBMX2 FRG1 CHAF1A UBR4 BRD9 EIF5B CCAR1 DKC1 ACIN1 PSMD2 AFDN PSMD7 CHD2 RPS25 THOC2 PSMA8 AP3D1 HSP90AA1 HP1BP3 EIF3CL | 9.43e-19 | 1403 | 81 | 34 | int:NR2C2 |
| Interaction | SMC5 interactions | EPRS1 PARP1 ZNF609 TAF3 MED19 UBN1 SFSWAP MAP1B PRPF4 BAZ2A BAZ1A RBBP6 CHAF1A BRD4 HMGXB4 BRD9 ANKRD11 EIF5B CCAR1 DKC1 ACIN1 AFDN PHF14 BOD1L1 RPS25 THOC2 MECP2 HSP90AA1 HP1BP3 | 6.86e-18 | 1000 | 81 | 29 | int:SMC5 |
| Interaction | BRD3 interactions | PARP1 TAF3 MED19 SFSWAP BAZ1A RBBP6 CHAF1A BRD4 HMGXB4 BRD9 EIF5B ACIN1 BRD3 TAF7 THOC2 MECP2 HP1BP3 EIF3CL | 8.25e-13 | 494 | 81 | 18 | int:BRD3 |
| Interaction | HECTD1 interactions | FAM133B EPRS1 PARP1 MED19 SFSWAP MAP1B UPF2 MYCBP2 FAM133A AIMP1 PRPF4 BAZ1A RBBP6 FRG1 MYO18A ANKRD11 DKC1 ACIN1 PSMD2 RPS25 THOC2 AP3D1 HP1BP3 | 3.41e-12 | 984 | 81 | 23 | int:HECTD1 |
| Interaction | MYCN interactions | FAM133B EPRS1 PARP1 ZNF609 SFSWAP FAM32A MAP1B UPF2 TCOF1 AIMP1 RBBP6 RBMX2 FRG1 HMGXB4 BRD9 EIF5B DKC1 ACIN1 AKAP13 PSMD7 CHD2 RPS25 THOC2 MECP2 HSP90AA1 HP1BP3 | 1.08e-11 | 1373 | 81 | 26 | int:MYCN |
| Interaction | EED interactions | EPRS1 PARP1 MAP1B TCOF1 MYCBP2 BAZ2A BAZ1A RBBP6 FRG1 BRD4 UBR4 HMGXB4 MYO18A EIF5B CCAR1 DKC1 ACIN1 PSMD1 PSMD2 AFDN CHD2 RPS25 THOC2 AP3D1 HSP90AA1 HP1BP3 | 3.39e-11 | 1445 | 81 | 26 | int:EED |
| Interaction | JMJD6 interactions | DOCK1 RABL6 MED19 SFSWAP USP42 FAM133A RBMX2 BRD4 HMGXB4 BRD9 DKC1 TAF7 | 3.40e-11 | 205 | 81 | 12 | int:JMJD6 |
| Interaction | SRPK2 interactions | SFSWAP TCOF1 MYCBP2 PRPF4 BAZ1A RBBP6 RBMX2 UBR4 HMGXB4 CCAR1 DKC1 ACIN1 AKAP13 CHD2 BRD3 HSP90AB2P DNAJC2 HP1BP3 HSP90AA2P | 4.48e-11 | 717 | 81 | 19 | int:SRPK2 |
| Interaction | MEN1 interactions | EPRS1 ZNF609 UPF2 TCOF1 PRPF4 BAZ2A BAZ1A RBBP6 FRG1 UBR4 EIF5B DKC1 ACIN1 AFDN BOD1L1 RPS25 EIF3C TAF7 THOC2 AP3D1 HSP90AA1 HP1BP3 | 6.32e-11 | 1029 | 81 | 22 | int:MEN1 |
| Interaction | CHD4 interactions | RABL6 EPRS1 PARP1 SFSWAP TCOF1 PRPF4 BAZ2A RBBP6 CHAF1A BRD4 CHD5 HMGXB4 CCAR1 DKC1 ACIN1 PHF14 BRD3 RPS25 EIF3C MECP2 HP1BP3 | 8.13e-11 | 938 | 81 | 21 | int:CHD4 |
| Interaction | MEPCE interactions | DOCK1 EPRS1 PARP1 AIMP1 PRPF4 FRG1 BRD4 CCAR1 PSMD1 PSMD2 PSMD7 BRD3 RPS25 EIF3C HSP90AB2P HSP90AA5P MECP2 HSP90AA1 HP1BP3 HSP90AA2P | 1.26e-10 | 859 | 81 | 20 | int:MEPCE |
| Interaction | BRD2 interactions | PARP1 TAF3 MED19 PRPF4 BAZ2A CHAF1A BRD4 HMGXB4 BRD9 DKC1 ACIN1 BRD3 TAF7 MECP2 HP1BP3 | 1.48e-10 | 429 | 81 | 15 | int:BRD2 |
| Interaction | KCNA3 interactions | DOCK1 RABL6 EPRS1 PARP1 MAP1B TCOF1 RBBP6 MYO18A EIF5B PSMD1 PSMD2 AFDN BOD1L1 CHD2 RPS25 TAF7 PARD3 THOC2 AP3D1 HSP90AA1 | 1.61e-10 | 871 | 81 | 20 | int:KCNA3 |
| Interaction | LARP7 interactions | EPRS1 PARP1 TCOF1 PRPF4 BAZ2A FRG1 BRD4 UBR4 DKC1 PSMD1 PSMD2 PSMD7 CHD2 BRD3 RPS25 EIF3C HSP90AB2P HSP90AA5P PSMA8 HSP90AA1 HP1BP3 HSP90AA2P | 2.82e-10 | 1113 | 81 | 22 | int:LARP7 |
| Interaction | CENPA interactions | PARP1 TAF3 BAZ2A BAZ1A FRG1 CHAF1A HMGXB4 BRD9 ANKRD11 PHF14 BRD3 THOC2 MECP2 HP1BP3 | 2.96e-10 | 377 | 81 | 14 | int:CENPA |
| Interaction | H3-3A interactions | EPRS1 PARP1 TAF3 UBN1 BAZ2A BAZ1A FRG1 CHAF1A BRD4 CHD5 HMGXB4 BRD9 PHF14 BOD1L1 CHD2 BRD3 MECP2 HP1BP3 | 7.59e-10 | 749 | 81 | 18 | int:H3-3A |
| Interaction | H3C3 interactions | PARP1 BAZ2A BAZ1A RBMX2 FRG1 CHAF1A BRD4 CHD5 HMGXB4 BRD9 PHF14 BOD1L1 BRD3 MECP2 HP1BP3 | 1.06e-09 | 495 | 81 | 15 | int:H3C3 |
| Interaction | EFTUD2 interactions | SMAP1 EPRS1 PARP1 SLC4A7 TCOF1 AIMP1 PRPF4 FRG1 CHAF1A BRD4 UBR4 EIF5B DKC1 PSMD1 PSMD2 AKAP13 RPS25 EIF3C HSP90AB2P MECP2 AP3D1 HSP90AA1 DNAJC2 HP1BP3 | 1.28e-09 | 1449 | 81 | 24 | int:EFTUD2 |
| Interaction | PRPF8 interactions | EPRS1 PARP1 MAP1B AIMP1 PRPF4 RBBP6 FRG1 CHAF1A BRD4 UBR4 EIF5B PSMD2 BOD1L1 RPS25 HSP90AB2P THOC2 MECP2 HSP90AA1 | 1.33e-09 | 776 | 81 | 18 | int:PRPF8 |
| Interaction | TNIP1 interactions | FAM133B EPRS1 PARP1 TCOF1 RBBP6 RBMX2 FRG1 CHD5 BRD9 MYO18A EIF5B DKC1 PSMD2 RPS25 EIF3C THOC2 HSP90AA5P AP3D1 HSP90AA1 HP1BP3 EIF3CL HSP90AA2P | 1.51e-09 | 1217 | 81 | 22 | int:TNIP1 |
| Interaction | H3C1 interactions | CYLC2 EPRS1 PARP1 TAF3 UBN1 BAZ2A BAZ1A WDR87 FRG1 CHAF1A BRD4 UBR4 HMGXB4 MYO18A DKC1 BRD3 EIF3C MECP2 HP1BP3 | 2.07e-09 | 901 | 81 | 19 | int:H3C1 |
| Interaction | UFL1 interactions | EPRS1 PARP1 SFSWAP MAP1B UPF2 BRD4 SEC62 EIF5B ACIN1 PSMD1 PSMD2 PSMD7 RPS25 THOC2 MECP2 AP3D1 HSP90AA1 DNAJC2 HP1BP3 EIF3CL | 3.01e-09 | 1031 | 81 | 20 | int:UFL1 |
| Interaction | DDX23 interactions | TAF3 SFSWAP MAP1B TCOF1 PRPF4 RBBP6 RBMX2 BRD4 ANKRD11 DKC1 ACIN1 CHD2 THOC2 MECP2 | 6.64e-09 | 480 | 81 | 14 | int:DDX23 |
| Interaction | CHD3 interactions | EPRS1 PARP1 SFSWAP PRPF4 BAZ1A CHAF1A BRD4 CHD5 HMGXB4 CCAR1 DKC1 ACIN1 PHF14 RPS25 EIF3C HSP90AA1 HP1BP3 | 6.67e-09 | 757 | 81 | 17 | int:CHD3 |
| Interaction | H2BC4 interactions | EPRS1 PARP1 MAP1B UPF2 AIMP1 BRD4 CHD5 ANKRD11 EIF3C AP3D1 HP1BP3 | 7.00e-09 | 259 | 81 | 11 | int:H2BC4 |
| Interaction | NAA40 interactions | EPRS1 PARP1 MAP1A MAP1B TCOF1 BAZ2A BAZ1A RBBP6 EIF5B DKC1 ACIN1 BOD1L1 PSMD7 EIF3C THOC2 MECP2 AP3D1 HSP90AA1 HP1BP3 | 7.90e-09 | 978 | 81 | 19 | int:NAA40 |
| Interaction | POLR1G interactions | TAF3 FAM32A TCOF1 RBMX2 CHAF1A BRD4 UBR4 ANKRD11 DKC1 PHF14 PSMD7 CHD2 BRD3 MECP2 | 8.40e-09 | 489 | 81 | 14 | int:POLR1G |
| Interaction | STIP1 interactions | EPRS1 PARP1 FAM32A AIMP1 PRPF4 UBR4 EIF5B CCAR1 DKC1 PSMD1 PSMD2 PSMD7 RPS25 EIF3C HSP90AB2P THOC2 HSP90AA5P AP3D1 HSP90AA1 | 1.25e-08 | 1006 | 81 | 19 | int:STIP1 |
| Interaction | EIF5B interactions | BRD4 UBR4 EIF5B DKC1 BOD1L1 BRD3 EIF3C MECP2 HSP90AA1 DNAJC2 | 1.32e-08 | 212 | 81 | 10 | int:EIF5B |
| Interaction | DPF2 interactions | RABL6 PARP1 FAM32A UPF2 FAM133A AIMP1 BRD4 HMGXB4 BRD9 BRD3 MECP2 HSP90AA2P | 1.46e-08 | 349 | 81 | 12 | int:DPF2 |
| Interaction | CSNK2A1 interactions | TCOF1 FAM133A BAZ1A BRD4 BRD9 ANKRD11 EIF5B DKC1 ACIN1 BRD3 RPS25 EIF3C HSP90AB2P TAF7 MECP2 HSP90AA1 HP1BP3 EIF3CL | 3.40e-08 | 956 | 81 | 18 | int:CSNK2A1 |
| Interaction | PNN interactions | PARP1 SFSWAP FAM133A RBBP6 RBMX2 BRD4 BRD9 ACIN1 BRD3 TRDN MECP2 | 3.41e-08 | 302 | 81 | 11 | int:PNN |
| Interaction | HSP90AB1 interactions | PARP1 FAM32A MAP1B MYCBP2 BRD4 UBR4 CCAR1 ACIN1 PSMD1 BOD1L1 CHD2 HSP90AB2P THOC2 HSP90AA5P TRDN MECP2 HSP90AA1 HSP90AA2P | 3.63e-08 | 960 | 81 | 18 | int:HSP90AB1 |
| Interaction | CIT interactions | TCOF1 PRPF4 RBBP6 CHAF1A UBR4 MYO18A EIF5B DKC1 ACIN1 PSMD2 BOD1L1 CHD2 BRD3 RPS25 HSP90AB2P PARD3 THOC2 NKAPL HSP90AA1 HP1BP3 EIF3CL HSP90AA2P | 3.68e-08 | 1450 | 81 | 22 | int:CIT |
| Interaction | NPM1 interactions | EPRS1 PARP1 TAF3 MAP1B WDR87 RBMX2 CHAF1A BRD4 DKC1 PSMD1 CCDC80 BRD3 RPS25 EIF3C THOC2 TRDN MECP2 HSP90AA1 DNAJC2 HP1BP3 | 3.91e-08 | 1201 | 81 | 20 | int:NPM1 |
| Interaction | HSP90B1 interactions | MAP1B UPF2 TCOF1 AIMP1 BRD4 SEC62 HMGXB4 PSMD2 AKAP13 PSMD7 EIF3C SH3RF3 MECP2 HSP90AA1 DNAJC2 | 4.10e-08 | 650 | 81 | 15 | int:HSP90B1 |
| Interaction | ACE2 interactions | EPRS1 PARP1 TCOF1 AIMP1 CHAF1A UBR4 DKC1 ACIN1 PSMD1 PSMD2 PSMD7 RPS25 EIF3C PARD3 SLC4A5 AP3D1 HSP90AA1 DNAJC2 HP1BP3 | 5.65e-08 | 1106 | 81 | 19 | int:ACE2 |
| Interaction | ZC3H18 interactions | EPRS1 PARP1 SFSWAP TCOF1 AIMP1 PRPF4 RBBP6 RBMX2 BRD4 DKC1 ACIN1 RPS25 EIF3C THOC2 MECP2 HSP90AA1 HP1BP3 | 5.76e-08 | 877 | 81 | 17 | int:ZC3H18 |
| Interaction | HMGB1 interactions | CYLC2 PARP1 TAF3 MAP1B BRD4 EIF5B CCAR1 ACIN1 PSMD2 RPS25 MECP2 HSP90AA1 HP1BP3 | 6.70e-08 | 486 | 81 | 13 | int:HMGB1 |
| Interaction | ECT2 interactions | EPRS1 PARP1 MED19 TCOF1 MYCBP2 BRD9 MYO18A EIF5B DKC1 ACIN1 PSMD1 BOD1L1 HSP90AB2P PARD3 HSP90AA5P EIF3CL HSP90AA2P | 6.78e-08 | 887 | 81 | 17 | int:ECT2 |
| Interaction | USP14 interactions | PARP1 MAP1B AIMP1 BRD4 MYO18A EIF5B PSMD1 PSMD2 PHF14 PSMD7 RPS25 EIF3C HP1BP3 | 7.20e-08 | 489 | 81 | 13 | int:USP14 |
| Interaction | DDRGK1 interactions | EPRS1 PARP1 TCOF1 AIMP1 PRPF4 RBMX2 FRG1 SEC62 UBR4 MYO18A EIF5B DKC1 PSMD2 PSMD7 RPS25 THOC2 AP3D1 HSP90AA1 HP1BP3 EIF3CL | 7.45e-08 | 1249 | 81 | 20 | int:DDRGK1 |
| Interaction | CAND1 interactions | PARP1 SFSWAP MAP1B TCOF1 PRPF4 FRG1 CHAF1A BRD4 EIF5B CCAR1 DKC1 RPS25 HSP90AB2P MECP2 HSP90AA1 HP1BP3 HSP90AA2P | 7.59e-08 | 894 | 81 | 17 | int:CAND1 |
| Interaction | POU5F1 interactions | PARP1 TCOF1 USP42 FRG1 BRD4 CHD5 UBR4 EIF5B ACIN1 PSMD2 AFDN BRD3 RPS25 AP3D1 | 7.71e-08 | 584 | 81 | 14 | int:POU5F1 |
| Interaction | PRP4K interactions | PARP1 UPF2 PRPF4 BAZ1A BRD4 ACIN1 AKAP13 BRD3 THOC2 MECP2 HSP90AA1 | 8.14e-08 | 329 | 81 | 11 | int:PRP4K |
| Interaction | EIF3C interactions | PARP1 MAP1B CHAF1A BRD4 EIF5B PSMD1 EIF3C MECP2 DNAJC2 EIF3CL | 1.01e-07 | 263 | 81 | 10 | int:EIF3C |
| Interaction | RECQL4 interactions | EPRS1 PARP1 MAP1A MAP1B TCOF1 AIMP1 PRPF4 WDR87 EIF5B DKC1 PSMD1 PSMD2 PSMD7 RPS25 EIF3C HSP90AB2P HSP90AA5P PSMA8 HSP90AA1 HP1BP3 HSP90AA2P | 1.14e-07 | 1412 | 81 | 21 | int:RECQL4 |
| Interaction | SFSWAP interactions | 1.16e-07 | 96 | 81 | 7 | int:SFSWAP | |
| Interaction | SND1 interactions | EPRS1 PARP1 AIMP1 BRD4 SEC62 EIF5B ACIN1 RPS25 HSP90AA1 HP1BP3 EIF3CL | 1.39e-07 | 347 | 81 | 11 | int:SND1 |
| Interaction | RUVBL2 interactions | PARP1 MAP1B PRPF4 CHAF1A BRD4 DKC1 PSMD1 BRD3 HSP90AB2P TAF7 MECP2 HSP90AA1 HP1BP3 HSP90AA2P | 1.48e-07 | 616 | 81 | 14 | int:RUVBL2 |
| Interaction | CEBPB interactions | EPRS1 PARP1 TCOF1 AIMP1 PRPF4 BAZ2A BAZ1A BRD4 EIF5B CCAR1 DKC1 ACIN1 PSMD1 PSMD2 PHF14 RPS25 EIF3C HSP90AB2P TAF7 HSP90AA1 HP1BP3 | 1.65e-07 | 1443 | 81 | 21 | int:CEBPB |
| Interaction | SMARCC2 interactions | RABL6 PARP1 UBN1 UPF2 MYCBP2 BAZ1A CHAF1A BRD4 BRD9 BRD3 MECP2 | 1.65e-07 | 353 | 81 | 11 | int:SMARCC2 |
| Interaction | NSD2 interactions | 1.68e-07 | 278 | 81 | 10 | int:NSD2 | |
| Interaction | NUP43 interactions | ZNF609 TAF3 FAM32A BAZ2A BAZ1A RBBP6 RBMX2 FRG1 ANKRD11 DKC1 ACIN1 BOD1L1 MECP2 HP1BP3 | 1.77e-07 | 625 | 81 | 14 | int:NUP43 |
| Interaction | PYHIN1 interactions | PARP1 UBN1 MAP1B TCOF1 PRPF4 BAZ2A BAZ1A EIF5B PHF14 MECP2 HP1BP3 | 1.90e-07 | 358 | 81 | 11 | int:PYHIN1 |
| Interaction | ZNF330 interactions | PARP1 TAF3 BAZ1A FRG1 CHAF1A HMGXB4 ANKRD11 DKC1 PHF14 BRD3 MECP2 HP1BP3 | 2.12e-07 | 446 | 81 | 12 | int:ZNF330 |
| Interaction | SIRT7 interactions | MAP1B TCOF1 MYCBP2 BAZ2A BRD4 UBR4 EIF5B CCAR1 ACIN1 PSMD1 PSMD2 AFDN CHD2 THOC2 HP1BP3 | 2.36e-07 | 744 | 81 | 15 | int:SIRT7 |
| Interaction | PRC1 interactions | IQCA1L RBBP6 BRD4 CHD5 BRD9 MYO18A EIF5B DKC1 ACIN1 PSMD1 PSMD2 PHF14 PSMD7 NKAPL MECP2 HP1BP3 HSP90AA2P | 2.54e-07 | 973 | 81 | 17 | int:PRC1 |
| Interaction | MBD2 interactions | 2.73e-07 | 161 | 81 | 8 | int:MBD2 | |
| Interaction | RAD18 interactions | FAM133B EPRS1 PARP1 SFSWAP PRPF4 RBBP6 RBMX2 BRD4 CCAR1 ACIN1 BRD3 HP1BP3 | 2.75e-07 | 457 | 81 | 12 | int:RAD18 |
| Interaction | WDR5 interactions | EPRS1 PARP1 AIMP1 PRPF4 CHAF1A BRD4 UBR4 BRD9 MYO18A DKC1 ACIN1 PSMD1 PSMD2 AFDN BOD1L1 EIF3C TAF7 HSP90AA1 | 2.82e-07 | 1101 | 81 | 18 | int:WDR5 |
| Interaction | MAP1LC3B interactions | DOCK1 RABL6 PARP1 MAP1A MAP1B UPF2 TCOF1 BAZ1A SEC62 BRD9 BRD3 TAF7 HSP90AA1 | 2.84e-07 | 551 | 81 | 13 | int:MAP1LC3B |
| Interaction | TERF2IP interactions | PARP1 ZNF609 SFSWAP BAZ2A RBBP6 CHAF1A BRD4 HMGXB4 ANKRD11 CCAR1 BOD1L1 THOC2 HP1BP3 | 2.90e-07 | 552 | 81 | 13 | int:TERF2IP |
| Interaction | DDX41 interactions | 3.45e-07 | 166 | 81 | 8 | int:DDX41 | |
| Interaction | ZCCHC10 interactions | 4.46e-07 | 236 | 81 | 9 | int:ZCCHC10 | |
| Interaction | CAMKV interactions | 4.79e-07 | 118 | 81 | 7 | int:CAMKV | |
| Interaction | SSRP1 interactions | PARP1 PRPF4 RBBP6 CHAF1A BRD4 HMGXB4 ANKRD11 CCAR1 DKC1 ACIN1 PHF14 CHD2 BRD3 MECP2 | 5.34e-07 | 685 | 81 | 14 | int:SSRP1 |
| Interaction | ATG16L1 interactions | RABL6 FAM133B PARP1 MED19 SFSWAP FAM32A MAP1A MYCBP2 RBBP6 RBMX2 BRD9 CCAR1 PSMD2 AKAP13 EIF3C TAF7 HSP90AA1 DNAJC2 | 6.14e-07 | 1161 | 81 | 18 | int:ATG16L1 |
| Interaction | SUMO2 interactions | EPRS1 PARP1 AIMP1 BAZ1A CHAF1A BRD4 UBR4 HMGXB4 ACIN1 BOD1L1 BRD3 HSP90AA1 HP1BP3 | 6.28e-07 | 591 | 81 | 13 | int:SUMO2 |
| Interaction | H2BC12 interactions | 6.49e-07 | 322 | 81 | 10 | int:H2BC12 | |
| Interaction | DOT1L interactions | EPRS1 SFSWAP TCOF1 AIMP1 PRPF4 BAZ1A RBBP6 CCAR1 ACIN1 BRD3 RPS25 EIF3C THOC2 HSP90AA1 HP1BP3 | 6.63e-07 | 807 | 81 | 15 | int:DOT1L |
| Interaction | KPNA3 interactions | 6.75e-07 | 248 | 81 | 9 | int:KPNA3 | |
| Interaction | HERC2 interactions | MED19 SFSWAP MYCBP2 USP42 BRD4 UBR4 EIF5B DKC1 PSMD1 PSMD2 EIF3C AP3D1 | 7.60e-07 | 503 | 81 | 12 | int:HERC2 |
| Interaction | ENY2 interactions | 8.20e-07 | 186 | 81 | 8 | int:ENY2 | |
| Interaction | RPL5 interactions | PARP1 UPF2 TCOF1 RBMX2 BRD4 DKC1 RPS25 EIF3C HSP90AA5P MECP2 HSP90AA1 DNAJC2 HP1BP3 | 8.32e-07 | 606 | 81 | 13 | int:RPL5 |
| Interaction | CSNK2A2 interactions | PARP1 TCOF1 FAM133A PRPF4 BRD4 PHF14 PSMD7 BRD3 RPS25 EIF3C HSP90AB2P NKAPL HSP90AA1 EIF3CL | 9.35e-07 | 718 | 81 | 14 | int:CSNK2A2 |
| Interaction | PSMA7 interactions | 1.07e-06 | 262 | 81 | 9 | int:PSMA7 | |
| Interaction | PSMD2 interactions | EPRS1 PARP1 SFSWAP MAP1B PRPF4 BRD4 PSMD1 PSMD2 PSMD7 PSMA8 AP3D1 | 1.30e-06 | 435 | 81 | 11 | int:PSMD2 |
| Interaction | YAP1 interactions | FAM133B EPRS1 PARP1 TAF3 TCOF1 BAZ2A RBBP6 BRD4 ACIN1 PSMD2 AFDN BOD1L1 RPS25 TAF7 PARD3 THOC2 HSP90AA1 | 1.31e-06 | 1095 | 81 | 17 | int:YAP1 |
| Interaction | SNRNP40 interactions | ZNF609 UBN1 SFSWAP TCOF1 USP42 PRPF4 BAZ2A RBBP6 BRD4 CCAR1 DKC1 ACIN1 MECP2 | 1.45e-06 | 637 | 81 | 13 | int:SNRNP40 |
| Interaction | TAF3 interactions | 1.46e-06 | 88 | 81 | 6 | int:TAF3 | |
| Interaction | SNRNP70 interactions | RABL6 SFSWAP MAP1B UPF2 PRPF4 RBBP6 FRG1 BRD4 EIF5B CCAR1 DKC1 ACIN1 RPS25 THOC2 MECP2 HP1BP3 | 1.56e-06 | 984 | 81 | 16 | int:SNRNP70 |
| Interaction | MAP1B interactions | EPRS1 MAP1A MAP1B TCOF1 AIMP1 UBR4 PSMD2 BOD1L1 EIF3C MECP2 HSP90AA1 EIF3CL | 1.57e-06 | 539 | 81 | 12 | int:MAP1B |
| Interaction | EIF3A interactions | CHAF1A BRD4 EIF5B DKC1 PHF14 RPS25 EIF3C AP3D1 DNAJC2 EIF3CL | 1.57e-06 | 355 | 81 | 10 | int:EIF3A |
| Interaction | RPS4X interactions | EPRS1 BRD4 UBR4 DKC1 RPS25 EIF3C TRDN MECP2 HSP90AA1 DNAJC2 HP1BP3 EIF3CL | 1.60e-06 | 540 | 81 | 12 | int:RPS4X |
| Interaction | SUZ12 interactions | EPRS1 PARP1 TAF3 USP42 CHAF1A BRD4 HMGXB4 DKC1 ACIN1 PHF14 CHD2 THOC2 HP1BP3 | 1.64e-06 | 644 | 81 | 13 | int:SUZ12 |
| Interaction | PRPF40A interactions | RABL6 PARP1 UPF2 FAM133A RBMX2 BRD4 UBR4 ACIN1 BRD3 THOC2 MECP2 | 1.66e-06 | 446 | 81 | 11 | int:PRPF40A |
| Interaction | CEBPA interactions | EPRS1 PARP1 ZNF609 FAM32A MYCBP2 PRPF4 BAZ1A FRG1 BRD4 BRD9 EIF5B CCAR1 ACIN1 PSMD7 RPS25 THOC2 MECP2 HP1BP3 | 1.68e-06 | 1245 | 81 | 18 | int:CEBPA |
| Interaction | BRCA1 interactions | EPRS1 PARP1 TCOF1 FAM133A AIMP1 CHAF1A BRD4 UBR4 BRD9 EIF5B PSMD1 PSMD2 PSMD7 RPS25 HSP90AB2P NKAPL HSP90AA1 HP1BP3 | 1.76e-06 | 1249 | 81 | 18 | int:BRCA1 |
| Interaction | RICTOR interactions | EPRS1 PARP1 SFSWAP MAP1B HMGXB4 BRD9 MYO18A PSMD2 AFDN RPS25 HSP90AB2P NKAPL HSP90AA1 HSP90AA2P | 1.80e-06 | 759 | 81 | 14 | int:RICTOR |
| Interaction | PRPF19 interactions | EPRS1 PARP1 TCOF1 PRPF4 RBBP6 FRG1 BRD4 UBR4 HSP90AB2P MECP2 HSP90AA1 | 1.81e-06 | 450 | 81 | 11 | int:PRPF19 |
| Interaction | U2AF2 interactions | EPRS1 PARP1 MAP1B PRPF4 BRD4 CCAR1 DKC1 ACIN1 PSMD1 PSMD2 BRD3 MECP2 HSP90AA1 | 1.84e-06 | 651 | 81 | 13 | int:U2AF2 |
| Interaction | HSP90AA1 interactions | EPRS1 FAM32A MAP1B WDR87 BRD4 UBR4 EIF5B CCAR1 PSMD1 BOD1L1 HSP90AB2P THOC2 HSP90AA5P TRDN MECP2 HSP90AA1 HP1BP3 HSP90AA2P | 2.06e-06 | 1263 | 81 | 18 | int:HSP90AA1 |
| Interaction | BOD1L1 interactions | 2.31e-06 | 149 | 81 | 7 | int:BOD1L1 | |
| Interaction | SLFN11 interactions | PARP1 MAP1B PRPF4 RBBP6 EIF5B CCAR1 DKC1 RPS25 EIF3C HSP90AA1 | 2.62e-06 | 376 | 81 | 10 | int:SLFN11 |
| Interaction | SF3A1 interactions | PARP1 TCOF1 PRPF4 RBBP6 CHAF1A BRD4 CCAR1 ACIN1 PSMD1 PSMD7 MECP2 | 2.81e-06 | 471 | 81 | 11 | int:SF3A1 |
| Interaction | MBD3 interactions | 2.83e-06 | 295 | 81 | 9 | int:MBD3 | |
| Interaction | HEXIM1 interactions | EPRS1 PARP1 TCOF1 PRPF4 BRD4 CHD5 PSMD1 PSMD2 PSMD7 RPS25 EIF3C MECP2 PSMA8 HSP90AA1 HP1BP3 | 3.07e-06 | 913 | 81 | 15 | int:HEXIM1 |
| Interaction | H2BC8 interactions | PARP1 PRPF4 BAZ2A BAZ1A FRG1 CHAF1A BRD4 HMGXB4 PHF14 BRD3 MECP2 HP1BP3 | 3.11e-06 | 576 | 81 | 12 | int:H2BC8 |
| GeneFamily | PHD finger proteins | 3.19e-06 | 90 | 46 | 5 | 88 | |
| GeneFamily | Proteasome | 4.21e-06 | 43 | 46 | 4 | 690 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 3.43e-04 | 11 | 46 | 2 | 1025 | |
| GeneFamily | PDZ domain containing | 6.79e-03 | 152 | 46 | 3 | 1220 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 8.04e-03 | 53 | 46 | 2 | 103 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.09e-02 | 181 | 46 | 3 | 694 | |
| GeneFamily | Solute carriers | 1.78e-02 | 395 | 46 | 4 | 752 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | SMIM24 UBN1 UPF2 BAZ2A BRD4 BRD9 ANKRD11 EIF5B CCAR1 ACIN1 PHF14 AKAP13 CHD2 SLC4A4 THOC2 AP3D1 | 1.09e-13 | 417 | 79 | 16 | M39224 |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | FAM133B SMAP1 EPRS1 TCOF1 FAM133A AIMP1 BAZ1A FRG1 SEC62 ANKRD11 EIF5B ACIN1 PSMD2 PSMD7 RPS25 EIF3C HSP90AA1 DNAJC2 HP1BP3 EIF3CL | 1.22e-10 | 1144 | 79 | 20 | MM3843 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | RABL6 SMAP1 PARP1 MED19 FAM32A MYCBP2 RBMX2 FRG1 BRD4 SEC62 UBR4 EIF5B PSMD1 PSMD7 BRD3 MECP2 HP1BP3 | 3.43e-08 | 1129 | 79 | 17 | M42508 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | RABL6 SMAP1 PARP1 MED19 FAM32A MYCBP2 RBMX2 FRG1 BRD4 SEC62 UBR4 EIF5B PSMD1 PSMD7 BRD3 MECP2 HP1BP3 | 4.96e-08 | 1158 | 79 | 17 | MM1338 |
| Coexpression | TABULA_MURIS_SENIS_LIVER_ENDOTHELIAL_CELL_OF_HEPATIC_SINUSOID_AGEING | FAM32A MYCBP2 AIMP1 FRG1 SEC62 BRD9 BOD1L1 BRD3 RPS25 TNFAIP2 HP1BP3 | 5.09e-08 | 418 | 79 | 11 | MM3752 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | SMAP1 SFSWAP TCOF1 MYCBP2 AIMP1 BAZ1A FRG1 BRD4 UBR4 EIF5B PSMD7 DNAJC2 | 2.90e-07 | 612 | 79 | 12 | MM3804 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 SLC4A7 MAP1B UPF2 MYCBP2 BAZ1A HMGXB4 PHF14 AKAP13 PARD3 THOC2 MECP2 DNAJC2 | 1.58e-06 | 856 | 79 | 13 | M4500 |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 2.31e-06 | 198 | 79 | 7 | M6123 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 2.58e-06 | 32 | 79 | 4 | MM1307 | |
| Coexpression | GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP | 3.27e-06 | 134 | 79 | 6 | M455 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP | FAM133B SMAP1 EPRS1 PARP1 UPF2 MYCBP2 FRG1 PHF14 TAF7 THOC2 HSP90AA1 | 4.41e-06 | 658 | 79 | 11 | M40871 |
| Coexpression | RICKMAN_METASTASIS_UP | 1.07e-05 | 350 | 79 | 8 | M9752 | |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 1.46e-05 | 49 | 79 | 4 | MM1178 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | PARP1 UBN1 UPF2 TCOF1 PRPF4 BAZ2A BAZ1A RBBP6 FRG1 CHAF1A EIF5B DKC1 RPS25 THOC2 DNAJC2 | 1.55e-05 | 1394 | 79 | 15 | M9585 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | PARP1 AIMP1 PRPF4 BAZ1A RBBP6 FRG1 CHAF1A EIF5B DKC1 HSP90AA1 DNAJC2 | 1.72e-05 | 761 | 79 | 11 | M11961 |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | SMAP1 ZNF609 MED19 SLC4A7 FAM32A AIMP1 FRG1 BRD4 DKC1 PSMD7 BRD3 PARD3 HSP90AA1 | 2.09e-05 | 1088 | 79 | 13 | MM3699 |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 2.94e-05 | 197 | 79 | 6 | M7546 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN | 2.94e-05 | 197 | 79 | 6 | M5786 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PARP1 ZNF609 SLC4A7 MYCBP2 USP42 BAZ1A RBBP6 UBR4 ANKRD11 AKAP13 BOD1L1 CHD2 RPS25 TAF7 MECP2 | 3.41e-05 | 1492 | 79 | 15 | M40023 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_INTERMEDIATE_MONOCYTE_AGEING | 3.86e-05 | 419 | 79 | 8 | MM3768 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | DOCK1 MAP1A MAP1B MYCBP2 BRD4 AKAP13 BRD3 RPS25 TNFAIP2 HSP90AA1 | 3.95e-05 | 685 | 79 | 10 | MM3782 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 3.99e-05 | 208 | 79 | 6 | MM581 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 5.59e-05 | 221 | 79 | 6 | M39222 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SMAP1 EPRS1 ZNF609 SLC4A7 SFSWAP UPF2 PRPF4 BAZ1A RBBP6 SEC62 EIF5B PSMD2 THOC2 | 6.53e-05 | 1215 | 79 | 13 | M41122 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 8.13e-05 | 466 | 79 | 8 | M13522 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.10e-04 | 250 | 79 | 6 | M11318 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 1.23e-04 | 32 | 79 | 3 | M2334 | |
| Coexpression | BENPORATH_CYCLING_GENES | 1.44e-04 | 648 | 79 | 9 | M8156 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 1.51e-04 | 380 | 79 | 7 | M41703 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 1.58e-04 | 656 | 79 | 9 | M18979 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 1.70e-04 | 519 | 79 | 8 | M3395 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 1.88e-04 | 394 | 79 | 7 | MM3724 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 2.06e-04 | 680 | 79 | 9 | M41089 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 2.07e-04 | 534 | 79 | 8 | MM1054 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 2.20e-04 | 284 | 79 | 6 | M16975 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 2.31e-04 | 543 | 79 | 8 | MM997 | |
| Coexpression | ZHENG_CORD_BLOOD_C3_MEGAKARYOCYTE_ERYTHROID_PROGENITOR | 2.41e-04 | 100 | 79 | 4 | M39212 | |
| Coexpression | EIF4E_DN | 2.41e-04 | 100 | 79 | 4 | M2790 | |
| Coexpression | YAGI_AML_WITH_INV_16_TRANSLOCATION | 2.43e-04 | 411 | 79 | 7 | M1047 | |
| Coexpression | DER_IFN_BETA_RESPONSE_UP | 2.69e-04 | 103 | 79 | 4 | M13453 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 2.70e-04 | 295 | 79 | 6 | M39121 | |
| Coexpression | VEGF_A_UP.V1_DN | 2.98e-04 | 193 | 79 | 5 | M2675 | |
| Coexpression | GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 3.20e-04 | 196 | 79 | 5 | M7551 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP | 3.35e-04 | 198 | 79 | 5 | M5170 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 3.51e-04 | 200 | 79 | 5 | M291 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 3.51e-04 | 200 | 79 | 5 | M8050 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP | 3.51e-04 | 200 | 79 | 5 | M5817 | |
| Coexpression | GSE13306_TREG_VS_TCONV_SPLEEN_UP | 3.51e-04 | 200 | 79 | 5 | M3224 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP | 3.51e-04 | 200 | 79 | 5 | M7808 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 3.51e-04 | 200 | 79 | 5 | M7500 | |
| Coexpression | GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP | 3.51e-04 | 200 | 79 | 5 | M3035 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP | 3.51e-04 | 200 | 79 | 5 | M4323 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CLASSICAL_MONOCYTE_AGEING | 3.72e-04 | 441 | 79 | 7 | MM3765 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 3.76e-04 | 203 | 79 | 5 | MM3795 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | 3.87e-04 | 444 | 79 | 7 | M41713 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_T_CELL_AGEING | 3.93e-04 | 445 | 79 | 7 | MM3853 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 4.02e-04 | 206 | 79 | 5 | M2817 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | ZNF609 MYCBP2 SEC62 AKAP13 CHD2 RPS25 TAF7 MECP2 HSP90AA1 HP1BP3 | 4.03e-04 | 911 | 79 | 10 | M40038 |
| Coexpression | MILI_PSEUDOPODIA | 4.13e-04 | 48 | 79 | 3 | M17507 | |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 4.13e-04 | 48 | 79 | 3 | M1568 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR | 4.66e-04 | 458 | 79 | 7 | M1606 | |
| Coexpression | CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS | 4.66e-04 | 50 | 79 | 3 | M1702 | |
| Coexpression | MILI_PSEUDOPODIA | 4.94e-04 | 51 | 79 | 3 | MM824 | |
| Coexpression | KAYO_AGING_MUSCLE_DN | 5.45e-04 | 124 | 79 | 4 | M17261 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR | 6.38e-04 | 483 | 79 | 7 | MM1012 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | RABL6 SMAP1 SLC4A7 SLC4A8 MAP1B UPF2 TCOF1 USP42 BAZ1A RBBP6 ZGRF1 RBMX2 BRD4 EIF5B CCAR1 DKC1 PHF14 BOD1L1 THOC2 SLC4A5 HSP90AA1 DNAJC2 | 7.53e-09 | 1459 | 78 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | RABL6 SMAP1 SLC4A7 SLC4A8 UPF2 TCOF1 USP42 BAZ1A RBBP6 ZGRF1 RBMX2 BRD4 EIF5B CCAR1 DKC1 PHF14 BOD1L1 THOC2 HSP90AA1 DNAJC2 | 1.76e-08 | 1257 | 78 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.14e-07 | 186 | 78 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SMAP1 EPRS1 SLC4A7 SLC4A8 MAP1A MAP1B TCOF1 BAZ1A RBBP6 CCAR1 PHF14 BOD1L1 CHD2 TAF7 HSP90AA1 DNAJC2 | 4.92e-07 | 989 | 78 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | DOCK1 SLC4A7 UPF2 BAZ1A ANKRD11 EIF5B CCAR1 EIF3C PARD3 SH3RF3 DNAJC2 | 1.11e-06 | 469 | 78 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.08e-06 | 311 | 78 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | FAM133B EPRS1 MED19 SLC4A7 MAP1B BAZ1A ANKRD11 EIF5B ACIN1 EIF3C DNAJC2 | 3.76e-06 | 532 | 78 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | RABL6 EPRS1 TAF3 SLC4A7 UPF2 MYCBP2 USP42 ZGRF1 PSMD1 CHD2 THOC2 | 6.55e-06 | 564 | 78 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | SMIM24 EPRS1 PARP1 SLC4A7 MAP1B TCOF1 BAZ2A BAZ1A RBMX2 DKC1 EIF3C TAF7 HSP90AA1 DNAJC2 | 1.33e-05 | 991 | 78 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 1.68e-05 | 403 | 78 | 9 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | EPRS1 SLC4A8 MAP1B BAZ1A RBBP6 BRD9 CCAR1 PHF14 BOD1L1 CHD2 MECP2 DNAJC2 | 4.81e-05 | 831 | 78 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.06e-04 | 204 | 78 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SMAP1 SLC4A8 BAZ1A RBBP6 BRD9 MYO18A CCAR1 PHF14 CHD2 MECP2 HP1BP3 | 1.26e-04 | 780 | 78 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SLC4A7 SFSWAP HMGXB4 ANKRD11 EIF5B DKC1 ACIN1 PSMD7 CHD2 THOC2 CNGA1 | 1.68e-04 | 806 | 78 | 11 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 2.29e-04 | 150 | 78 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.69e-04 | 362 | 78 | 7 | gudmap_developingGonad_e18.5_testes_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | PARP1 SLC4A7 MAP1B TCOF1 RBMX2 CHAF1A BRD4 EIF5B CCAR1 DKC1 TAF7 SLC4A5 HSP90AA1 DNAJC2 | 4.25e-04 | 1371 | 78 | 14 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 4.45e-04 | 492 | 78 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.78e-04 | 378 | 78 | 7 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 4.82e-04 | 498 | 78 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 4.90e-04 | 629 | 78 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | UBN1 SFSWAP IQCA1 HMGXB4 ANKRD11 ACIN1 CHD2 TAF7 THOC2 PSMA8 | 5.45e-04 | 778 | 78 | 10 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | RABL6 SMAP1 BAZ1A BRD4 EIF5B CCAR1 DKC1 PHF14 BOD1L1 SLC4A4 THOC2 HSP90AA1 DNAJC2 | 5.51e-04 | 1241 | 78 | 13 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | SMAP1 TAF3 SLC4A7 TCOF1 BAZ1A BRD4 EIF5B CCAR1 PHF14 BOD1L1 THOC2 HSP90AA1 DNAJC2 | 5.99e-04 | 1252 | 78 | 13 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.34e-04 | 285 | 78 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.72e-04 | 524 | 78 | 8 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 7.10e-04 | 192 | 78 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | TAF3 MAP1B UPF2 RBBP6 BRD9 EIF5B CCAR1 PHF14 BOD1L1 CHD2 THOC2 HSP90AA1 DNAJC2 | 4.21e-17 | 197 | 81 | 13 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.78e-11 | 192 | 81 | 9 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.98e-09 | 198 | 81 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.10e-09 | 199 | 81 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.10e-09 | 199 | 81 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.10e-09 | 199 | 81 | 8 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-08 | 187 | 81 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-08 | 188 | 81 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 6.60e-08 | 194 | 81 | 7 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 7.08e-08 | 196 | 81 | 7 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 7.85e-08 | 199 | 81 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.13e-08 | 200 | 81 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 1.52e-06 | 195 | 81 | 6 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.71e-06 | 199 | 81 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.71e-06 | 199 | 81 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.76e-06 | 200 | 81 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.79e-05 | 177 | 81 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 186 | 81 | 5 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 186 | 81 | 5 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 189 | 81 | 5 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 191 | 81 | 5 | 45023854f285ac465f23ea1b33c970e14992e709 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 191 | 81 | 5 | 6890a8e4b4530987a5b044614fcd7e00716a4d66 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 192 | 81 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-05 | 192 | 81 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.85e-05 | 195 | 81 | 5 | 32ec72103faccc9e37c0ecedff1998e7df6a19f6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 195 | 81 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 195 | 81 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-05 | 196 | 81 | 5 | 44007f0c14e0f0703f7ee715b8eababb4d80a8b5 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 3.07e-05 | 198 | 81 | 5 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 3.14e-05 | 199 | 81 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.14e-05 | 199 | 81 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.22e-05 | 200 | 81 | 5 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-05 | 200 | 81 | 5 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-05 | 200 | 81 | 5 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.17e-04 | 138 | 81 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| Computational | Neighborhood of RAD54L | 3.11e-04 | 105 | 61 | 5 | MORF_RAD54L | |
| Computational | Neighborhood of RFC1 | 3.70e-04 | 109 | 61 | 5 | MORF_RFC1 | |
| Computational | Neighborhood of DDB1 | 4.59e-04 | 246 | 61 | 7 | MORF_DDB1 | |
| Computational | Neighborhood of CASP2 | 4.62e-04 | 27 | 61 | 3 | GCM_CASP2 | |
| Computational | Neighborhood of NPM1 | 7.24e-04 | 72 | 61 | 4 | GNF2_NPM1 | |
| Computational | Genes in the cancer module 28. | 7.67e-04 | 32 | 61 | 3 | MODULE_28 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | EPRS1 SLC4A7 UBN1 MYCBP2 BAZ1A RBBP6 CHAF1A BRD4 HMGXB4 ANKRD11 EIF5B AKAP13 THOC2 AP3D1 | 1.69e-15 | 177 | 80 | 14 | 985_DN |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | EPRS1 UBN1 MYCBP2 PRPF4 BAZ1A RBBP6 HMGXB4 ANKRD11 AKAP13 AP3D1 | 6.79e-10 | 178 | 80 | 10 | 3998_DN |
| Drug | AC1L9M3Z | 2.16e-07 | 38 | 80 | 5 | CID000448575 | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.23e-07 | 179 | 80 | 8 | 4585_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.38e-07 | 189 | 80 | 8 | 1045_DN | |
| Drug | Pu x | 8.29e-07 | 6 | 80 | 3 | CID000448976 | |
| Drug | AC1L2E5V | 3.14e-06 | 29 | 80 | 4 | CID000019458 | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.02e-06 | 185 | 80 | 7 | 1673_DN | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; HL60; HG-U133A | 4.47e-06 | 188 | 80 | 7 | 1395_UP | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 5.50e-06 | 194 | 80 | 7 | 4312_DN | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; HL60; HG-U133A | 5.50e-06 | 194 | 80 | 7 | 1611_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.69e-06 | 195 | 80 | 7 | 1080_DN | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 5.88e-06 | 196 | 80 | 7 | 4844_DN | |
| Drug | FK-506; Down 200; 1uM; MCF7; HG-U133A | 6.49e-06 | 199 | 80 | 7 | 284_DN | |
| Drug | AC1L3HJJ | 1.16e-05 | 13 | 80 | 3 | CID000089287 | |
| Drug | 2qfo | 1.22e-05 | 2 | 80 | 2 | CID000600769 | |
| Drug | 3-amino-5-chlorobenzoic acid | 1.22e-05 | 2 | 80 | 2 | CID010986726 | |
| Drug | 3eko | 1.22e-05 | 2 | 80 | 2 | CID011160307 | |
| Drug | monocillin III | 1.22e-05 | 2 | 80 | 2 | CID006478910 | |
| Drug | pochonin A | 1.22e-05 | 2 | 80 | 2 | CID006478909 | |
| Drug | 1uyi | 1.22e-05 | 2 | 80 | 2 | CID005289232 | |
| Drug | PU-H71 | 1.22e-05 | 2 | 80 | 2 | CID009549213 | |
| Drug | NSC683666 | 1.22e-05 | 2 | 80 | 2 | CID005469153 | |
| Drug | H 64 | 1.22e-05 | 2 | 80 | 2 | CID006914564 | |
| Drug | SureCN4151355 | 1.22e-05 | 2 | 80 | 2 | CID015942101 | |
| Drug | 1uyc | 1.22e-05 | 2 | 80 | 2 | CID000448969 | |
| Drug | PU-9 | 1.22e-05 | 2 | 80 | 2 | CID000448971 | |
| Drug | P u 0 | 1.22e-05 | 2 | 80 | 2 | CID000448974 | |
| Drug | 2qf6 | 1.22e-05 | 2 | 80 | 2 | CID013373715 | |
| Drug | CHEBI:42139 | 1.22e-05 | 2 | 80 | 2 | CID011562562 | |
| Drug | OTX015 | 2.26e-05 | 16 | 80 | 3 | ctd:C000605331 | |
| Drug | thiolutin | 2.26e-05 | 16 | 80 | 3 | CID000006870 | |
| Drug | pyrimidin-2-one beta-ribofuranoside | 2.44e-05 | 48 | 80 | 4 | ctd:C009131 | |
| Drug | boron | 3.39e-05 | 257 | 80 | 7 | CID005462311 | |
| Drug | pochonin D | 3.65e-05 | 3 | 80 | 2 | CID006478913 | |
| Drug | azaquinone | 3.65e-05 | 3 | 80 | 2 | CID000099132 | |
| Drug | d 1 v | 3.65e-05 | 3 | 80 | 2 | CID000683940 | |
| Drug | HM-9 | 3.65e-05 | 3 | 80 | 2 | CID000433437 | |
| Drug | Glyoxylspermidine | 3.65e-05 | 3 | 80 | 2 | CID000133564 | |
| Drug | AC1MD0RC | 3.65e-05 | 3 | 80 | 2 | CID002829073 | |
| Drug | NCI60_002052 | 4.56e-05 | 20 | 80 | 3 | CID006801032 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 4.84e-05 | 185 | 80 | 6 | 831_UP | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; HL60; HT_HG-U133A | 4.84e-05 | 185 | 80 | 6 | 1833_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; HL60; HG-U133A | 4.99e-05 | 186 | 80 | 6 | 1555_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.14e-05 | 187 | 80 | 6 | 4323_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.78e-05 | 191 | 80 | 6 | 1059_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; HL60; HG-U133A | 6.31e-05 | 194 | 80 | 6 | 1585_DN | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 1323_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 3311_UP | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 1526_DN | |
| Drug | Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 7262_UP | |
| Drug | NSC325316 | 7.03e-05 | 23 | 80 | 3 | CID000331608 | |
| Drug | Lowicryl HM20 | 7.03e-05 | 23 | 80 | 3 | CID000174488 | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 2623_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 2000uM; MCF7; HG-U133A | 7.26e-05 | 199 | 80 | 6 | 346_DN | |
| Drug | uranyl chloride | 7.28e-05 | 4 | 80 | 2 | CID000082259 | |
| Drug | methoxyhydroquinone | 7.28e-05 | 4 | 80 | 2 | CID000069988 | |
| Drug | 11p110 | 7.28e-05 | 4 | 80 | 2 | CID002382787 | |
| Drug | Probucol [23288-49-5]; Down 200; 7.8uM; HL60; HG-U133A | 7.46e-05 | 200 | 80 | 6 | 1608_DN | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; PC3; HT_HG-U133A | 7.46e-05 | 200 | 80 | 6 | 7134_DN | |
| Drug | indolo(3,2-b)carbazole | 1.03e-04 | 69 | 80 | 4 | ctd:C075954 | |
| Drug | 1uy7 | 1.21e-04 | 5 | 80 | 2 | CID005289227 | |
| Drug | Bortezomib | 1.21e-04 | 5 | 80 | 2 | DB00188 | |
| Drug | 1uyd | 1.21e-04 | 5 | 80 | 2 | CID000448970 | |
| Drug | Org 31806 | 1.21e-04 | 5 | 80 | 2 | CID000164147 | |
| Drug | CRT0044876 | 1.21e-04 | 5 | 80 | 2 | CID000081409 | |
| Drug | HCV-796 | 1.21e-04 | 5 | 80 | 2 | CID011561383 | |
| Drug | chaetochromin | 1.21e-04 | 5 | 80 | 2 | CID000053277 | |
| Drug | 1,1-diphenyl-2-propyn-1-ol | 1.21e-04 | 5 | 80 | 2 | CID000092976 | |
| Drug | AC1L9LJU | 1.23e-04 | 137 | 80 | 5 | CID000448056 | |
| Drug | Hantzsch ester | 1.81e-04 | 6 | 80 | 2 | CID000070849 | |
| Drug | 3-aminocoumarin | 1.81e-04 | 6 | 80 | 2 | CID000074217 | |
| Drug | ARV-825 | 1.81e-04 | 6 | 80 | 2 | ctd:C000606252 | |
| Drug | H2DIDS | 2.11e-04 | 33 | 80 | 3 | CID000115184 | |
| Drug | 17-aminogeldanamycin | 2.53e-04 | 7 | 80 | 2 | CID000429444 | |
| Drug | Nepl | 2.53e-04 | 7 | 80 | 2 | CID006439214 | |
| Drug | NSC330499 | 2.53e-04 | 7 | 80 | 2 | CID000433447 | |
| Drug | 1,2,4,7,8-pentachlorodibenzo-p-dioxin | 2.53e-04 | 7 | 80 | 2 | CID000042836 | |
| Drug | Zlll-mca | 2.53e-04 | 7 | 80 | 2 | CID000132936 | |
| Drug | dienochlor | 2.53e-04 | 7 | 80 | 2 | CID000016686 | |
| Drug | 15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.68e-04 | 162 | 80 | 5 | 1069_UP | |
| Drug | nocodazole | 2.71e-04 | 477 | 80 | 8 | CID000004122 | |
| Drug | 3-aminobenzoic acid | 2.98e-04 | 37 | 80 | 3 | CID000007419 | |
| Drug | phenyldichloroarsine | 3.37e-04 | 8 | 80 | 2 | CID000012762 | |
| Drug | GGMP | 3.37e-04 | 8 | 80 | 2 | CID006443839 | |
| Drug | D-box | 3.37e-04 | 8 | 80 | 2 | CID000133881 | |
| Drug | 9-phenanthrol | 3.37e-04 | 8 | 80 | 2 | CID000010229 | |
| Drug | Velcade (bortezomib | 3.46e-04 | 374 | 80 | 7 | CID000093860 | |
| Drug | EIPA | 3.53e-04 | 95 | 80 | 4 | CID000001795 | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 3.72e-04 | 174 | 80 | 5 | 1302_UP | |
| Drug | boldine | 4.04e-04 | 41 | 80 | 3 | CID000010154 | |
| Drug | 5,8-quinolinedione | 4.32e-04 | 9 | 80 | 2 | CID000388306 | |
| Drug | antheridiol | 4.32e-04 | 9 | 80 | 2 | CID000159927 | |
| Drug | JJ3 | 4.32e-04 | 9 | 80 | 2 | CID009927355 | |
| Drug | boceprevir | 4.32e-04 | 9 | 80 | 2 | CID010324367 | |
| Drug | nibentan | 4.32e-04 | 9 | 80 | 2 | CID000177905 | |
| Drug | noviose | 4.32e-04 | 9 | 80 | 2 | CID005461025 | |
| Drug | quinol | 4.46e-04 | 181 | 80 | 5 | CID000000785 | |
| Drug | Retinoic acid [302-79-4]; Down 200; 13.4uM; HL60; HG-U133A | 5.05e-04 | 186 | 80 | 5 | 1548_DN | |
| Drug | AC1L1DW2 | 5.05e-04 | 186 | 80 | 5 | CID000002532 | |
| Disease | anemia (implicated_via_orthology) | 5.72e-08 | 15 | 77 | 4 | DOID:2355 (implicated_via_orthology) | |
| Disease | Alopecia, Male Pattern | 6.90e-04 | 15 | 77 | 2 | C4083212 | |
| Disease | Androgenetic Alopecia | 6.90e-04 | 15 | 77 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 6.90e-04 | 15 | 77 | 2 | C0263477 | |
| Disease | skin sensitivity to sun | 1.12e-03 | 19 | 77 | 2 | EFO_0004795 | |
| Disease | Pseudopelade | 1.12e-03 | 19 | 77 | 2 | C0086873 | |
| Disease | Alopecia | 1.12e-03 | 19 | 77 | 2 | C0002170 | |
| Disease | Intellectual Disability | 1.12e-03 | 447 | 77 | 6 | C3714756 | |
| Disease | Epilepsy, Cryptogenic | 1.30e-03 | 82 | 77 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.30e-03 | 82 | 77 | 3 | C0751111 | |
| Disease | Aura | 1.30e-03 | 82 | 77 | 3 | C0236018 | |
| Disease | Autism Spectrum Disorders | 1.45e-03 | 85 | 77 | 3 | C1510586 | |
| Disease | Neurodevelopmental Disorders | 1.87e-03 | 93 | 77 | 3 | C1535926 | |
| Disease | Child Development Disorders, Specific | 2.61e-03 | 29 | 77 | 2 | C0085997 | |
| Disease | Child Development Deviations | 2.61e-03 | 29 | 77 | 2 | C0085996 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KERAKSKEKKSEKKE | 1186 | Q9UKV3 | |
| LSKKEKKEKKKREKE | 161 | P55196 | |
| EKEKKKKDKEKEKEK | 496 | Q15059 | |
| KKDKEKEKEKHKVKA | 501 | Q15059 | |
| DKKEKVFEKHKEKKD | 1196 | Q6UB99 | |
| KKEKKAKRKKKDEDE | 106 | Q8TDI0 | |
| KDKKEKKKEKHKRKE | 541 | O60885 | |
| ERHKEKKKKKKKKSE | 61 | Q9H8M2 | |
| KEDKKEKDKKSKKDE | 796 | Q8IX12 | |
| EKDKKSKKDERKDKK | 801 | Q8IX12 | |
| KQKEAKKKSKAEKEK | 746 | Q9UIF9 | |
| KKAKEKIEKKGEKKE | 121 | Q12904 | |
| KSKEKEKEKDKIKEK | 1761 | Q12802 | |
| EKEKDKIKEKEKDSK | 1766 | Q12802 | |
| KIKEKEKDSKDKEKD | 1771 | Q12802 | |
| KEEKLDAKKDSKKGK | 151 | Q14093 | |
| KKDAKKNAKKDAKKD | 316 | Q14093 | |
| DAKKDAKKNAKKDEK | 326 | Q14093 | |
| AKKNAKKDEKKDAKK | 331 | Q14093 | |
| KEEAKRAKEEAKKKK | 361 | Q13111 | |
| KKFKEEEKAKKEAEK | 281 | Q99543 | |
| QEEEEKNKKKKKKKE | 346 | Q86XH1 | |
| GKKKEKKAKKDKDLT | 476 | Q86XH1 | |
| EAKKKEKEDKEKKRE | 336 | Q9NRL2 | |
| KSEKKSKQEKEKSKK | 571 | Q76M96 | |
| KKEKKHKEKERDKEK | 846 | O14617 | |
| HKEKERDKEKKKEKE | 851 | O14617 | |
| RDKEKKKEKEKKKSP | 856 | O14617 | |
| KDEKDQSKEKEKKVK | 116 | Q5SSJ5 | |
| DEKPTKKHKKDKKEK | 151 | Q9Y388 | |
| KKKKKGKEEEEKAAK | 656 | Q3YEC7 | |
| VDEVAKKKSKKEKDK | 216 | P09874 | |
| KKKSKKEKDKDSKLE | 221 | P09874 | |
| SVKKKKKSKDETEKE | 156 | Q8N9E0 | |
| KEKISKLEEKKDKEK | 406 | P78559 | |
| KLEEKKDKEKKEIKK | 411 | P78559 | |
| KKDEGRKEEKKDAKK | 431 | P78559 | |
| KKEVKKEIKKEEKKE | 681 | P46821 | |
| DDSGKDKKKKTKKIK | 181 | Q58FF8 | |
| EKKEDKRKKKKESND | 66 | Q58FG0 | |
| EEEEKKDADKKKKKS | 91 | Q58FG0 | |
| KDADKKKKKSKEKYI | 96 | Q58FG0 | |
| KDGGRKEKKEKKEKK | 11 | Q92614 | |
| EDSKDAKKDSKKVKK | 301 | P35663 | |
| KDERKDTKKDKKKLK | 341 | P35663 | |
| DTKKDKKKLKKDDKK | 346 | P35663 | |
| KESQKDEKKDKKDSK | 416 | P35663 | |
| DEKKDKKDSKTDNKK | 421 | P35663 | |
| EKKGKKDSKKDDKKK | 461 | P35663 | |
| KDSKKDDKKKDAKKN | 466 | P35663 | |
| HSEKKKKKEEKDKER | 386 | Q9UGU5 | |
| PRKKKEKEKEKEKEK | 111 | O94880 | |
| AESQDSKKKKKKKEK | 1721 | Q7Z6E9 | |
| KKNKDKEKEKEKDDQ | 1771 | Q7Z6E9 | |
| KGERKKEKKEKTEKK | 331 | Q8NFC6 | |
| DKKAAEKKREDKAKK | 266 | Q99613 | |
| SKKKKSKDKKRKREE | 21 | Q14331 | |
| DKKAAEKKREDKAKK | 266 | B5ME19 | |
| DKDDLEKEKKDKKKE | 1686 | Q14185 | |
| EKEKKDKKKEKRNSK | 1691 | Q14185 | |
| KKKSKDGTEKEKDIK | 161 | Q5BKY9 | |
| KEGDKERKKSKDKKE | 1411 | O14647 | |
| KKKKKDKDKAKLLEA | 26 | Q9Y421 | |
| EEEKKDGDKKKKKKI | 266 | P07900 | |
| DGDSDTTKKKKKKKK | 491 | O60832 | |
| EEEKKDGDKKKKKTK | 266 | Q14568 | |
| DKTDRKKDKTGKEKK | 986 | Q8TEW0 | |
| KKDKTGKEKKKDRDK | 991 | Q8TEW0 | |
| KKEDKERKKKDEEKV | 66 | Q9HAU5 | |
| KKKKKEEDPDRKRKK | 201 | A0JLT2 | |
| LKFKKVKKDKKEEKE | 26 | P51608 | |
| KDKNKDKSKEKDKVK | 546 | Q5VWG9 | |
| DKSKEKDKVKEKEKD | 551 | Q5VWG9 | |
| KEKEKHKDKKKDREK | 611 | Q5VWG9 | |
| HKDKKKDREKGKKDK | 616 | Q5VWG9 | |
| GKKDKDKREKEKVKD | 626 | Q5VWG9 | |
| EEKEKVKEKEKKKDK | 691 | Q5VWG9 | |
| KKEKEKEKKEKEREK | 711 | Q5VWG9 | |
| PKASKKKDKDKEKKF | 116 | Q15545 | |
| EEEKEKKKKKHKKRS | 751 | Q12872 | |
| KDKKKKEKENKSEKQ | 961 | P07814 | |
| SKKKKEDDKKKKEKE | 1141 | Q9Y6M7 | |
| EKKKSDKRKKDKEKK | 1441 | Q13428 | |
| DKEKKEKKKKAKKAS | 1451 | Q13428 | |
| KKTKKDDEKSKKSKE | 146 | O43172 | |
| DSKEKEEDKDKKEKK | 621 | Q13200 | |
| EEDKDKKEKKDKDKK | 626 | Q13200 | |
| SKKDRKEDKEKDKDK | 296 | P51665 | |
| KDKDKEKSDVKKEEK | 306 | P51665 | |
| SKEKGKDEKEKKKGK | 356 | A6NCM1 | |
| KDEKEKKKGKEEKAK | 361 | A6NCM1 | |
| KGKKKKEKKKQDFDE | 41 | O60841 | |
| EDDNEGDKKKKDKKK | 306 | O60841 | |
| KDKKKKKGEKEEKEK | 316 | O60841 | |
| KKGEKEEKEKEKKKG | 321 | O60841 | |
| TAKAKKKEKEKEKKE | 836 | Q99460 | |
| KKEAKEKEEKRKKEK | 86 | O75264 | |
| EKEEKRKKEKKTAKE | 91 | O75264 | |
| KECEKENKKSKKEKK | 3196 | O75592 | |
| SKKKKLDDAKKKAKE | 1011 | Q2Y0W8 | |
| DKKKKDAGKSAKKDK | 6 | P62851 | |
| KEKKKKEEKSKDKKE | 131 | P29973 | |
| SDDDKKRVKAKKKKK | 216 | Q5M9Q1 | |
| KKSKKKKKSKDKHRD | 1196 | Q9H9J4 | |
| REEEEAAKKKKEKKK | 21 | Q03169 | |
| KEKGKEKEKEKKEKT | 1271 | Q8NI27 | |
| KEKEKFKKEEKAKDE | 1326 | Q8NI27 | |
| KDEKTKKEKEKKKDG | 131 | Q99442 | |
| KKEKEKKKDGEKEES | 136 | Q99442 | |
| GCKLDEKKSEKKEKK | 706 | Q8TEJ3 | |
| EDKKKKKKKKKDSVD | 121 | Q8NEW7 | |
| DKKKKDKKKKESSKE | 726 | O15014 | |
| KEKKETDKKRKRKKG | 1076 | Q9BY07 | |
| KNKLEKEKEKKKEEK | 161 | Q8IYB5 | |
| KEKEKKKEEKKREKE | 166 | Q8IYB5 | |
| ETKKKEKEDIKKKSE | 326 | Q13061 | |
| AKKDEKKEDSKKTKK | 371 | Q13061 | |
| KKKKKDDTYDKEKKS | 201 | Q9NPG3 | |
| EEKQKKKSEKEKSKD | 2086 | Q86YA3 | |
| IPEKDKKKKEDEKKK | 1006 | Q9Y6R1 | |
| EKEKEEAEKKKSKKS | 241 | Q8TAA3 | |
| STKKSKKEEKEKEKD | 3366 | Q5T4S7 | |
| EKEEEEKKKKKKEKK | 2281 | Q6ZQQ6 |